OMIM ID,Disease,Protein Associated
202110,"Isolated 17,20-lyase deficiency",CYP17A1
202110,"17-alpha-hydroxylase/17,20-lyase deficiency",CYP17A1
300438,17-beta-hydroxysteroid dehydrogenase X deficiency,HSD17B10
610006,2-methylbutyrylglycinuria,ACADSB
231530,3-hydroxyacyl-coa dehydrogenase deficiency,HADHSC
250620,3-hydroxyisobutryl-CoA hydrolase deficiency,HIBCH
273750,3-M syndrome,CUL7
210200,3-Methylcrotonyl-CoA carboxylase 1 deficiency,MCCC1
210210,3-Methylcrotonyl-CoA carboxylase 2 deficiency,MCCC2
250950,3-Methylglutaconic aciduria type I,AUH
258501,3-Methylglutaconic aciduria type III,OPA3
610198,3-Methylglutaconic aciduria type V,DNAJC19
400045,46XX true hermaphroditism,SRY
233420,46XY complete gonadal dysgenesis,DHH
400044,46XY complete gonadal dysgenesis,SRY
612965,"46XY gonadal dysgenesis, complete or partial, with or without adrenal failure",NR5A1
613080,"46XY gonadal dysgenesis, complete, CBS2-related",CBX2
607080,"46XY partial gonadal dysgenesis, with minifascicular neuropathy",DHH
274270,5-fluorouracil toxicity,DPYD
610460,6-mercaptopurine sensitivity,TPMT
305400,Aarskog–Scott syndrome,FGD1
600501,ABCD syndrome,EDNRB
200100,Abetalipoproteinemia,MTP
611126,ACAD9 deficiency,ACAD9
114290,Acampomelic campomelic dysplasia,SOX9
231550,Achalasia-Addisonianism-Alacrimia syndrome,AAAS
200500,Acheiropody,LMBR1
600972,Achondrogenesis Ib,SLC26A2
200600,Achondrogenesis type 1A,TRIP11
200610,Achondrogenesis-hypochondrogenesis type 2,COL2A1
100800,Achondroplasia,FGFR3
216900,Achromatopsia-2,CNGA3
262300,Achromatopsia-3,CNGB3
200990,Acrocallosal syndrome,GLI3
607778,Acrocapitofemoral dysplasia,IHH
201100,Acrodermatitis enteropathica,SLC39A4
101900,Acrokeratosis verruciformis,ATP2A2
201250,"Acromesomelic dysplasia, Hunter-Thompson type",GDF5
602875,"Acromesomelic dysplasia, Maroteaux type",NPR2
254900,Action myoclonus-renal failure syndrome,SCARB2
201460,"Acyl-CoA dehydrogenase, long chain, deficiency of",ACADL
201450,"Acyl-CoA dehydrogenase, medium chain, deficiency of",ACADM
201470,"Acyl-CoA dehydrogenase, short chain, deficiency of",ACADS
211980,"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in",EGFR
211980,"Adenocarcinoma of lung, somatic",BRAF
211980,"Adenocarcinoma of lung, somatic",ERBB2
211980,"Adenocarcinoma of lung, somatic",PRKN
604370,"Adenocarcinoma, ovarian, somatic",PRKN
608456,"Adenomas, multiple colorectal",MUTYH
181030,"Adenomas, salivary gland pleomorphic",PLAG1
175100,Adenomatous polyposis coli,APC
102700,"Adenosine deaminase deficiency, partial",ADA
102900,"Adenosine triphosphate, elevated, of erythrocytes",PKLR
103050,Adenylosuccinase deficiency,ADSL
612556,Adiponectin deficiency,ADIPOQ
202300,Adrenal cortical carcinoma,TP53
202010,"Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency",CYP11B1
201750,"Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency",POR
300200,"Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism",DAX1
201400,Adrenocorticotropic hormone deficiency,TBS19
300100,Adrenoleukodystrophy,ABCD1
202370,"Adrenoleukodystrophy, neonatal",PEX1
202370,"Adrenoleukodystrophy, neonatal",PEX10
202370,"Adrenoleukodystrophy, neonatal",PEX13
202370,"Adrenoleukodystrophy, neonatal",PEX26
202370,"Adrenoleukodystrophy, neonatal",PEX5
300100,Adrenomyeloneuropathy,ABCD1
110800,Adult i phenotype with congenital cataract,GCNT2
110800,Adult i phenotype without cataract,GCNT2
103285,ADULT syndrome,TP63
604348,"Advanced sleep phase syndrome, familial",PER2
202400,"Afibrinogenemia, congenital",FGA
202400,"Afibrinogenemia, congenital",FGB
601495,Agammaglobulinemia 1,IGHM
613500,Agammaglobulinemia 2,IGLL1
613502,Agammaglobulinemia 4,BLNK
613506,Agammaglobulinemia 5,LRRC8A
307200,Agammaglobulinemia and isolated hormone deficiency,BTK
300755,"Agammaglobulinemia, type 1, X-linked",BTK
612718,AGAT deficiency,GATM
218000,Agenesis of the corpus callosum with peripheral neuropathy,SLC12A6
225750,"Aicardi–Goutières syndrome 1, dominant and recessive",TREX1
610181,Aicardi–Goutières syndrome 2,RNASEH2B
610329,Aicardi–Goutières syndrome 3,RNASEH2C
610333,Aicardi–Goutières syndrome 4,RNASEH2A
612952,Aicardi–Goutières syndrome 5,SAMHD1
608688,AICA-ribosiduria due to ATIC deficiency,ATIC
610205,Alagille syndrome 2,NOTCH2
118450,Alagille syndrome,JAG1
300600,Aland Island eye disease,CACNA1F
203200,"Albinism, brown oculocutaneous",OCA2
203290,"Albinism, brown",TYRP1
203100,"Albinism, oculocutaneous, type IA",TYR
606952,"Albinism, oculocutaneous, type IB",TYR
203200,"Albinism, oculocutaneous, type II",OCA2
278400,"Albinism, rufous",TYRP1
610251,"Alcohol sensitivity, acute",ALDH2
103900,"Aldosteronism, glucocorticoid-remediable",CYP11B1
203450,Alexander disease,GFAP
203450,Alexander disease,NDUFV1
203500,Alkaptonuria,HGD
300523,Allan–Herndon–Dudley syndrome,SLC16A2
203655,Alopecia universalis,HR
612079,"Alopecia, neurologic defects, and endocrinopathy syndrome",RBM28
203700,Alpers syndrome,POLG
609889,"Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity",RAG1
262850,Alpha-2-plasmin inhibitor deficiency,PLI
203740,Alpha-ketoglutarate dehydrogenase deficiency,OGDH
203750,Alpha-methylacetoacetic aciduria,ACAT1
300448,"Alpha-thalassemia myelodysplasia syndrome, somatic",ATRX
301040,Alpha-thalassemia mental retardation syndrome,ATRX
301050,Alport syndrome,COL4A5
203780,"Alport syndrome, autosomal recessive",COL4A3
203780,"Alport syndrome, autosomal recessive",COL4A4
203800,Alström syndrome,ALMS1
104290,Alternating hemiplegia of childhood,ATP1A2
265380,Alveolar capillary dysplasia with misalignment of pulmonary veins,FOXF1
606243,Alveolar soft part sarcoma,ASPSCR1
104300,"Alzheimer disease 1, familial",APP
104300,Alzheimer disease 6,AD6
104300,Alzheimer disease 8,AD8
104300,"Alzheimer disease, late-onset, susceptibility to",NOS3
607822,"Alzheimer disease, type 3",PSEN1
607822,"Alzheimer disease, type 3, with spastic paraparesis and apraxia",PSEN1
607822,"Alzheimer disease, type 3, with spastic paraparesis and unusual plaques",PSEN1
104300,Alzheimer disease-10,AD10
104310,Alzheimer disease-2,APOE
606889,Alzheimer disease-4,PSEN2
104300,Alzheimer disease-5,AD5
613211,"Amelogenesis imperfecta, hypomaturation type, IIA3",WDR72
104510,"Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism",DLX3
301200,"Amelogenesis imperfecta, hypoplastic/hypomaturation type",AMELX
130900,"Amelogenesis imperfecta, type 3",FAM83H
104500,"Amelogenesis imperfecta, type IB",ENAM
204650,"Amelogenesis imperfecta, type IC",ENAM
204700,"Amelogenesis imperfecta, type IIA1",KLK4
612529,"Amelogenesis imperfecta, type IIA2",MMP20
609924,Aminoacylase 1 deficiency,ACY1
609056,Amish infantile epilepsy syndrome,SIAT9
105200,"Amyloidosis, 3 or more types",APOA1
105120,"Amyloidosis, Finnish type",GSN
105200,"Amyloidosis, hereditary renal",FGA
105210,"Amyloidosis, hereditary, transthyretin-related",TTR
105250,"Amyloidosis, primary localized cutaneous",OSMR
105200,"Amyloidosis, renal",LYZ
612069,"Amyotrophic lateral sclerosis 10, with or without FTD",TARDBP
612577,Amyotrophic lateral sclerosis 11,FIG4
602433,"Amyotrophic lateral sclerosis 4, juvenile",SETX
608030,"Amyotrophic lateral sclerosis 6, autosomal recessive",FUS
608627,Amyotrophic lateral sclerosis 8,VAPB
611895,Amyotrophic lateral sclerosis 9,ANG
105400,"Amyotrophic lateral sclerosis, due to SOD1 deficiency",SOD1
205100,"Amyotrophic lateral sclerosis, juvenile",ALS2
162100,"Amyotrophy, hereditary neuralgic",40430
613435,Amytrophic lateral sclerosis 12,OPTN
607095,Anauxetic dysplasia,RMRP
300068,Androgen insensitivity syndrome,AR
312300,"Androgen insensitivity, partial, with or without breast cancer",AR
224120,"Anemia, congenital dyserythropoietic, type I",CDAN1
224100,"Anemia, dyserythropoietic congenital, type II",SEC23B
266120,"Anemia, hemolytic, due to UMPH1 deficiency",NT5C3
268150,"Anemia, hemolytic, Rh-null, regulator type",RHAG
206100,"Anemia, hypochromic microcytic",NRAMP2
205950,"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive",GLRX5
205950,"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive",SLC25A38
301310,"Anemia, sideroblastic, with ataxia",ABCB7
300751,"Anemia, sideroblastic, X-linked",ALAS2
105830,Angelman syndrome,MECP2
105830,Angelman syndrome,UBE3A
105830,Angelman syndrome-like,CDKL5
610618,"Angioedema, hereditary, type III",F12
106100,"Angioedema, hereditary, types I and II",C1NH
611773,"Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps",COL4A1
106210,Aniridia,PAX6
206800,Anonychia congenita,RSPO4
107250,Anterior segment mesenchymal dysgenesis,FOXE3
107250,Anterior segment mesenchymal dysgenesis,PITX3
613118,Antithrombin III deficiency,AT3
207410,Antley–Bixler syndrome,FGFR2
201750,Antley–Bixler syndrome-like with disordered steroidogenesis,POR
607834,Anxiety-related personality traits,SLC6A4
132900,"Aortic aneurysm, familial thoracic 4",MYH11
611788,"Aortic aneurysm, familial thoracic 6",ACTA2
109730,Aortic valve disease,NOTCH1
101200,Apert syndrome,FGFR2
610256,"Aphakia, congenital primary",FOXE3
180920,Aplasia of lacrimal and salivary glands,FGF10
609135,Aplastic anemia,TERC
207800,Argininemia,ARG1
207900,Argininosuccinic aciduria,ASL
613546,Aromatase deficiency,CYP19A1
139300,Aromatase excess syndrome,CYP19A1
608643,Aromatic L-amino acid decarboxylase deficiency,DDC
107970,Arrhythmogenic right ventricular dysplasia 1,TGFB3
600996,Arrhythmogenic right ventricular dysplasia 2,RYR2
604400,Arrhythmogenic right ventricular dysplasia 5,LAMR1
607450,Arrhythmogenic right ventricular dysplasia 8,DSP
610193,"Arrhythmogenic right ventricular dysplasia, familial, 10",DSG2
610476,"Arrhythmogenic right ventricular dysplasia, familial, 11",DSC2
611528,"Arrhythmogenic right ventricular dysplasia, familial, 12",JUP
604400,"Arrhythmogenic right ventricular dysplasia, familial, 5",TMEM43
609040,"Arrhythmogenic right ventricular dysplasia, familial, 9",PKP2
208000,"Arterial calcification, generalized, of infancy",ENPP1
208050,Arterial tortuosity syndrome,SLC2A10
108120,"Arthrogryposis multiplex congenita, distal type 1",TPM2
601680,"Arthrogryposis multiplex congenita, distal type 2B",TNNI2
193700,"Arthrogryposis, distal, type 2A",MYH3
601680,"Arthrogryposis, distal, type 2B",MYH3
601680,"Arthrogryposis, distal, type 2B",TPM2
611890,"Arthrogryposis, lethal, with anterior horn cell disease",GLE1
208085,"Arthrogryposis, renal dysfunction, and cholestasis 1",VPS33B
613404,"Arthrogryposis, renal dysfunction, and cholestasis 2",VIPAR
208230,"Arthropathy, progressive pseudorheumatoid, of childhood",WISP3
601680,"Arthyrgryposis, distal, type 2B",TNNT3
301835,Arts syndrome,PRPS1
208400,Aspartylglucosaminuria,AGA
611263,Asphyxiating thoracic dystrophy 2,IFT80
613091,Asphyxiating thoracic dystrophy 3,DYNC2H1
208550,Asthma and nasal polyps,TBX21
277460,Ataxia with isolated vitamin E deficiency,TTPA
601238,"Ataxia, cerebellar, Cayman type",ATCAY
208920,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",APTX
606002,Ataxia–ocular apraxia-2,SETX
208900,Ataxia–telangiectasia,ATM
604391,Ataxia–telangiectasia-like disorder,MRE11A
256050,Atelosteogenesis II,SLC26A2
108721,"Atelosteogenesis, type III",FLNB
108720,"Atelostogenesis, type I",FLNB
601536,Athabaskan brainstem dysgenesis syndrome,HOXA1
147050,Atopy,SPINK5
604273,"ATP synthase deficiency, nuclear-encoded",ATPAF2
209300,Atransferrinemia,TF
608583,Atrial fibrillation,GJA5
607554,"Atrial fibrillation, familial, 3",KCNQ1
611493,"Atrial fibrillation, familial, 4",KCNE2
612201,"Atrial fibrillation, familial, 6",NPPA
612240,"Atrial fibrillation, familial, 7",KCNA5
611363,Atrial septal defect 4,TBX20
612794,Atrial septal defect 5,ACTC1
613087,Atrial septal defect 6,TLL1
108900,Atrial septal defect with atrioventricular conduction defects,NKX2E
607941,Atrial septal defect-2,GATA4
209500,Atrichia with papular lesions,HR
600309,Atrioventricular canal defect,AVSD1
600309,Atrioventricular septal defect,GJA1
606217,"Atrioventricular septal defect, partial, with heterotaxy syndrome",CRELD1
601071,"Auditory neuropathy, autosomal recessive, 1",OTOF
613385,"Autoimmune disease, syndromic multisystem",ITCH
601859,"Autoimmune lymphoproliferative syndrome, type IA",TNFRSF6
603909,"Autoimmune lymphoproliferative syndrome, type II",CASP10
607271,"Autoimmune lymphoproliferative syndrome, type IIB",CASP8
240300,"Autoimmune polyendocrinopathy syndrome, type I, with or without reversible metaphyseal dysplasia",AIRE
180500,"Axenfeld–Rieger syndrome, type 1",PITX2
602482,"Axenfeld–Rieger syndrome, type 3",FOXC1
270960,Azoospermia due to perturbations of meiosis,SYCP3
415000,Azoospermia,USP9Y
218600,Baller–Gerold syndrome,RECQL4
241850,Bamforth–Lazarus syndrome,FOXE1
153480,Bannayan–Riley–Ruvalcaba syndrome,PTEN
209900,Bardet–Biedl syndrome 1,BBS1
209900,Bardet–Biedl syndrome 10,BBS10
209900,Bardet–Biedl syndrome 11,TRIM32
209900,Bardet–Biedl syndrome 12,BBS12
209900,Bardet–Biedl syndrome 13,MKS1
209900,Bardet–Biedl syndrome 14,CEP290
209900,Bardet–Biedl syndrome 15,C2orf86
209900,Bardet–Biedl syndrome 2,BBS2
209900,Bardet–Biedl syndrome 3,ARL6
209900,Bardet–Biedl syndrome 4,BBS4
209900,Bardet–Biedl syndrome 5,BBS5
209900,Bardet–Biedl syndrome 6,MKKS
209900,Bardet–Biedl syndrome 7,BBS7
209900,Bardet–Biedl syndrome 8,TTC8
209900,Bardet–Biedl syndrome 9,PTHB1
604571,"Bare lymphocyte syndrome, type I",TAP1
604571,"Bare lymphocyte syndrome, type I",TAPBP
604571,"Bare lymphocyte syndrome, type I, due to TAP2 deficiency",TAP2
209920,"Bare lymphocyte syndrome, type II, complementation group A",MHC2TA
209920,"Bare lymphocyte syndrome, type II, complementation group C",RFX5
209920,"Bare lymphocyte syndrome, type II, complementation group D",RFXAP
209920,"Bare lymphocyte syndrome, type II, complementation group E",RFX5
302060,Barth syndrome,TAZ
149200,Bart–Pumphrey syndrome,GJB2
601678,"Bartter syndrome, type 1",SLC12A1
241200,"Bartter syndrome, type 2",KCNJ1
607364,"Bartter syndrome, type 3",CLCNKB
602522,"Bartter syndrome, type 4, digenic",CLCNKB
602522,"Bartter syndrome, type 4a",BSND
613090,"Bartter syndrome, type 4b, digenic",CLCNKA
605462,"Basal cell carcinoma, somatic",PTCH1
605462,"Basal cell carcinoma, somatic",PTCH2
605462,"Basal cell carcinoma, somatic",RASA1
109400,Basal cell nevus syndrome,PTCH1
607483,"Basal ganglia disease, biotin-responsive",SLC19A3
126700,Basal laminar drusen,HF1
209950,"BCG and salmonella infection, disseminated",IL12B
209950,"BCG infection, generalized familial",IFNGR1
123790,Beare–Stevenson cutis gyrata syndrome,FGFR2
300376,Becker muscular dystrophy,DMD
130650,Beckwith–Wiedemann syndrome,CDKN1C
130650,Beckwith–Wiedemann syndrome,H19
130650,Beckwith–Wiedemann syndrome,KCNQ10T1
130650,Beckwith–Wiedemann syndrome,NSD1
153670,"Bernard–Soulier syndrome, benign autosomal dominant",GP1BA
231200,"Bernard–Soulier syndrome, type A",GP1BA
231200,"Bernard–Soulier syndrome, type B",GP1BB
231200,"Bernard–Soulier syndrome, type C",GP9
153700,Best macular dystrophy,BEST1
611809,Bestrophinopathy,BEST1
613161,Beta-ureidopropionase deficiency,UPB1
158810,Bethlem myopathy,COL6A1
158810,Bethlem myopathy,COL6A2
158810,Bethlem myopathy,COL6A3
210370,Bietti crystalline corneoretinal dystrophy,CYP4V2
608980,Bifid nose with or without anorectal and renal anomalies,FREM1
613291,"Bile acid malabsorption, primary",SLC10A2
235555,"Bile acid synthesis defect, congenital, 2",AKR1D1
214950,"Bile acid synthesis defect, congenital, 4",AMACR
253260,Biotinidase deficiency,BTD
612292,Birk–Barel mental retardation dysmorphism syndrome,KCNK9
135150,Birt–Hogg–Dubé syndrome,FLCN
262000,Björnstad syndrome,BCS1L
109800,Bladder cancer,KRAS
109800,Bladder cancer,RB1
109800,"Bladder cancer, somatic",FGFR3
186580,Blau syndrome,NOD2
609821,Bleeding disorder due to P2RY12 defect,P2RY12
110100,"Blepharophimosis, epicanthus inversus, and ptosis, type 1",FOXL2
110100,"Blepharophimosis, epicanthus inversus, and ptosis, type 2",FOXL2
111150,Blood group--Lutheran inhibitor,KLF1
210900,Bloom syndrome,RECQL3
303700,Blue cone monochromacy,OPN1MW
303700,Blue cone monochromacy,OPN1LW
112310,Boomerang dysplasia,FLNB
301900,Börjeson–Forssman–Lehmann syndrome,PHF6
601536,Bosley–Salih–Alorainy syndrome,HOXA1
607475,Bothnia retinal dystrophy,RLBP1
211180,Bowen–Conradi syndrome,EMG1
608389,Brachiootic syndrome 3,SIX1
112500,Brachydactyly type A1,BDA1B
112500,Brachydactyly type A1,IHH
112600,Brachydactyly type A2,BMPR1B
112600,Brachydactyly type A2,GDF5
113000,Brachydactyly type B1,ROR2
611377,Brachydactyly type B2,NOG
113100,Brachydactyly type C,GDF5
113200,Brachydactyly type D,HOXD13
113300,Brachydactyly type E,HOXD13
613382,Brachydactyly type E2,PTHLH
610713,Brachydactyly-syndactyly syndrome,HOXD13
113500,Brachyolmia type 3,TRPV4
608415,Bradyopsia,RGS9
608415,Bradyopsia,RGS9BP
607595,Brain small vessel disease with Axenfeld-Rieger anomaly,COL4A1
607595,Brain small vessel disease with hemorrhage,COL4A1
113620,Branchiooculofacial syndrome,TFAP2A
610896,Branchiootorenal syndrome 2,SIX5
113650,Branchiootorenal syndrome with cataract,EYA1
113650,Branchiootorenal syndrome,EYA1
114480,Breast cancer,PPM1D
114480,Breast cancer,SLC22A1L
114480,Breast cancer,TP53
114480,"Breast cancer, early-onset",BRIP1
114480,"Breast cancer, invasive ductal",RAD54L
114480,"Breast cancer, somatic",AKT1
114480,"Breast cancer, somatic",KRAS
114480,"Breast cancer, somatic",PIK3CA
114480,"Breast cancer, somatic",RB1CC1
229200,Brittle cornea syndrome,ZNF469
601003,Brody myopathy,ATP2A1
211400,Bronchiectasis with or without elevated sweat chloride 1,SCNN1B
613021,Bronchiectasis with or without elevated sweat chloride 2,SCNN1A
613071,Bronchiectasis with or without elevated sweat chloride 3,SCNN1G
605041,Brooke–Spiegler syndrome,CYLD1
211530,Brown–Vialetto–Van Laere syndrome,C20orf54
609220,Bruck syndrome 2,PLOD2
601144,Brugada syndrome 1,SCN5A
611777,Brugada syndrome 2,GPD1L
611875,Brugada syndrome 3,CACNA1C
611876,Brugada syndrome 4,CACNB2
612838,Brugada syndrome 5,SCN1B
613119,Brugada syndrome 6,KCNE3
613120,Brugada syndrome 7,SCN3B
613123,Brugada syndrome 8,HCN4
300615,Brunner syndrome,MAOA
113970,Burkitt's lymphoma,MYC
166700,Buschke–Ollendorff syndrome,LEMD3
211750,C syndrome,CD96
609536,C5 deficiency,C5
612446,C6 deficiency,C6
610102,C7 deficiency,C7
114000,Caffey disease,COL1A1
114290,Campomelic dysplasia with autosomal sex reversal,SOX9
114290,Campomelic dysplasia,SOX9
208250,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,PRG4
131300,Camurati–Engelmann disease,TGFB1
271900,Canavan disease,ASPA
613108,"Candidiasis, familial chronic mucocutaneous, autosomal dominant",CLEC7A
212050,"Candidiasis, familial chronic mucocutaneous, autosomal recessive",CARD9
608354,Capillary malformation-arteriovenous malformation,RASA1
237300,Carbamoyl phosphate synthetase I deficiency,CPS1
602579,"Carbohydrate-deficient glycoprotein syndrome, type Ib",MPI
212070,Carboxypeptidase N deficiency,CPN1
114900,"Carcinoid tumors, intestinal",SDHD
600919,"Cardiac arrhythmia, ankyrin-B-related",ANK2
612838,"Cardiac conduction defect, nonspecific",SCN1B
604377,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency",SCO2
115150,Cardiofaciocutaneous syndrome,BRAF
115150,Cardiofaciocutaneous syndrome,KRAS
115150,Cardiofaciocutaneous syndrome,MAP2K1
115150,Cardiofaciocutaneous syndrome,MAP2K2
601493,"Cardiomyopathy, dilated 1C",LDB3
115200,"Cardiomyopathy, dilated",MYBPC3
115200,"Cardiomyopathy, dilated, 1A",LMNA
612158,"Cardiomyopathy, dilated, 1AA",ACTN2
612877,"Cardiomyopathy, dilated, 1BB",DSG2
613122,"Cardiomyopathy, dilated, 1CC",NEXN
601494,"Cardiomyopathy, dilated, 1D",TNNT2
613172,"Cardiomyopathy, dilated, 1DD",RBM20
601154,"Cardiomyopathy, dilated, 1E",SCN5A
613252,"Cardiomyopathy, dilated, 1EE",MYH6
613286,"Cardiomyopathy, dilated, 1FF",TNNI3
604145,"Cardiomyopathy, dilated, 1G",TTN
613642,"Cardiomyopathy, dilated, 1GG",SDHA
604765,"Cardiomyopathy, dilated, 1I",DES
605362,"Cardiomyopathy, dilated, 1J",EYA4
606685,"Cardiomyopathy, dilated, 1L",SGCD
607482,"Cardiomyopathy, dilated, 1M",CSRP3
607487,"Cardiomyopathy, dilated, 1N",TCAP
608569,"Cardiomyopathy, dilated, 1O",ABCC9
609909,"Cardiomyopathy, dilated, 1P",PLN
613424,"Cardiomyopathy, dilated, 1R",ACTC1
613426,"Cardiomyopathy, dilated, 1S",MYH7
611407,"Cardiomyopathy, dilated, 1W",VCL
611615,"Cardiomyopathy, dilated, 1X",FKTN
611878,"Cardiomyopathy, dilated, 1Y",TPM1
611879,"Cardiomyopathy, dilated, 1Z",TNNC1
611880,"Cardiomyopathy, dilated, 2A",TNNI3
300069,"Cardiomyopathy, dilated, 3A",TAZ
302045,"Cardiomyopathy, dilated, 3B",DMD
192600,"Cardiomyopathy, familial hypertrophic, 1",MYH7
608758,"Cardiomyopathy, familial hypertrophic, 10",MYL2
612098,"Cardiomyopathy, familial hypertrophic, 11",ACTC1
612124,"Cardiomyopathy, familial hypertrophic, 12",CSRP3
613243,"Cardiomyopathy, familial hypertrophic, 13",TNNC1
613251,"Cardiomyopathy, familial hypertrophic, 14",MYH6
613255,"Cardiomyopathy, familial hypertrophic, 15",VCL
192600,"Cardiomyopathy, familial hypertrophic",CAV3
192600,"Cardiomyopathy, familial hypertrophic",SLC25A4
115195,"Cardiomyopathy, familial hypertrophic, 2",TNNT2
115196,"Cardiomyopathy, familial hypertrophic, 3",TPM1
115197,"Cardiomyopathy, familial hypertrophic, 4",MYBPC3
608751,"Cardiomyopathy, familial hypertrophic, 8",MYL3
115210,"Cardiomyopathy, familial restrictive",TNNI3
612422,"Cardiomyopathy, familial restrictive, 3",TNNT2
600858,"Cardiomyopathy, hypertrophic 6, with WPW",PRKAG2
192600,"Cardiomyopathy, hypertrophic, midventricular, digenic",MYLK2
608837,Carney complex variant,MYH8
160980,"Carney complex, type 1",PRKAR1A
212140,"Carnitine deficiency, systemic primary",SLC22A5
609338,Carotid intimal medial thickness 1,PPARG
115430,"Carpal tunnel syndrome, familial",TTR
201000,Carpenter syndrome,RAB23
250250,Cartilage–hair hypoplasia,RMRP
604219,Cataract with late-onset corneal dystrophy,PAX6
611597,"Cataract, autosomal dominant, multiple types 1",BFSP2
601547,"Cataract, cerulean, type 2",CRYBB2
609741,"Cataract, congenital nuclear, 2",CRYBB3
611544,"Cataract, congenital nuclear, autosomal recessive 3",CRYBB1
600881,"Cataract, congenital zonular, with sutural opacities",CRYBA1
604219,"Cataract, congenital",BFSP2
608983,"Cataract, congenital, cerulean type, 3",CRYGD
302200,"Cataract, congenital, X-linked",NHS
604307,"Cataract, Coppock-like",CRYBB2
604307,"Cataract, Coppock-like",CRYGC
611391,"Cataract, cortical, juvenile-onset",BFSP1
115700,"Cataract, crystalline aculeiform",CRYGD
612018,"Cataract, juvenile, with microcornea and glucosuria",SLC16A12
604219,"Cataract, juvenile-onset",BFSP2
610425,"Cataract, lamellar 2",CRYBA4
116800,"Cataract, lamellar",HSF4
116800,"Cataract, Marner type",HSF4
601286,"Cataract, nonnuclear polymorphic congenital",CRYGD
604219,"Cataract, polymorphic and lamellar",MIP
613020,"Cataract, posterior polar, 1",EPHA2
605387,"Cataract, posterior polar, 3",CHMP4B
610623,"Cataract, posterior polar, 4",PITX3
610623,"Cataract, posterior polar, 4, syndromic",PITX3
607133,"Cataract, sutural, with punctate and cerulean opacities",CRYBB2
116200,"Cataract, zonular pulverulent-1",GJA8
601885,"Cataract, zonular pulverulent-3",GJA3
116150,Cataract-microcornea syndrome,GJA8
610474,CATSHL syndrome,FGFR3
607864,Caudal duplication anomaly,AXIN1
600145,Caudal regression syndrome,VANGL1
116860,Cavernous malformations of CNS and retina,CCM1
612300,CD59 deficiency,CD59
608957,"CD8 deficiency, familial",CD8A
212780,Cenani–Lenz syndactyly syndrome,LRP4
117000,Central core disease,RYR1
209880,Central hypoventilation syndrome,GDNF
209880,"Central hypoventilation syndrome, congenital",ASCL1
209880,"Central hypoventilation syndrome, congenital",BDNF
209880,"Central hypoventilation syndrome, congenital",EDN3
209880,"Central hypoventilation syndrome, congenital",PMX2B
209880,"Central hypoventilation syndrome, congenital",RET
613227,Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3,CA8
604290,Cerebellar ataxia,CP
224050,Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1,VLDLR
105150,Cerebral amyloid angiopathy,CST3
605714,"Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants",APP
125310,Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy,NOTCH3
603285,Cerebral cavernous malformations 3,PDCD10
116860,Cerebral cavernous malformations-1,CCM1
603284,Cerebral cavernous malformations-2,C7orf22
609528,"Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome",SNAP29
612936,"Cerebral palsy, spastic quadriplegic, 3",AP4M1
612900,"Cerebral palsy, spastic quadriplegic",KANK1
603513,"Cerebral palsy, spastic, symmetric, autosomal recessive",GAD1
611209,Cerebrocostomandibular-like syndrome,COG1
214150,Cerebrooculofacioskeletal syndrome 1,ERCC6
610756,Cerebrooculofacioskeletal syndrome 2,ERCC2
610758,Cerebrooculofacioskeletal syndrome 4,ERCC1
213700,Cerebrotendinous xanthomatosis,CYP27A1
600143,"Ceroid lipofuscinosis, neuronal 8",CLN8
610127,"Ceroid lipofuscinosis, neuronal, 10",CTSD
610951,"Ceroid lipofuscinosis, neuronal, 7",MFSD8
610003,"Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant",CLN8
256730,"Ceroid lipofuscinosis, neuronal 1, infantile",PPT1
204500,"Ceroid-lipofuscinosis, neuronal 2, classic late infantile",TPP1
204200,"Ceroid lipofuscinosis, neuronal 3, juvenile",CLN3
256731,"Ceroid-lipofuscinosis, neuronal-5, variant late infantile",CLN5
601780,"Ceroid-lipofuscinosis, neuronal-6, variant late infantile",CLN6
603956,"Cervical cancer, somatic",FGFR3
275630,Chanarin–Dorfman syndrome,ABHD5
169100,Char syndrome,TFAP2B
606595,"Charcot–Marie–Tooth disease, axonal, type 2F",HSPB1
607831,"Charcot–Marie–Tooth disease, axonal, type 2K",GDAP1
608673,"Charcot–Marie–Tooth disease, axonal, type 2L",HSPB8
606482,"Charcot–Marie–Tooth disease, axonal, type 2M",DNM2
613287,"Charcot–Marie–Tooth disease, axonal, type 2N",AARS
607706,"Charcot–Marie–Tooth disease, axonal, with vocal cord paresis",GDAP1
607791,"Charcot–Marie–Tooth disease, dominant intermediate 3",MPZ
606482,"Charcot–Marie–Tooth disease, dominant intermediate B",DNM2
608323,"Charcot–Marie–Tooth disease, dominant intermediate C",YARS
608340,"Charcot–Marie–Tooth disease, recessive intermediate, A",GDAP1
613641,"Charcot–Marie–Tooth disease, recessive intermediate, B",KARS
118220,Charcot–Marie–Tooth disease type 1A,PMP22
118200,Charcot–Marie–Tooth disease type 1B,MPZ
601098,Charcot–Marie–Tooth disease type 1C,LITAF
607678,Charcot–Marie–Tooth disease type 1D,EGR2
118300,Charcot–Marie–Tooth disease type 1E,PMP22
607734,Charcot–Marie–Tooth disease type 1F,NEFL
118210,Charcot–Marie–Tooth disease type 2A1,KIF1B
609260,Charcot–Marie–Tooth disease type 2A2,MFN2
600882,Charcot–Marie–Tooth disease type 2B,RAB7
605588,Charcot–Marie–Tooth disease type 2B1,LMNA
605589,Charcot–Marie–Tooth disease type 2B2,MED25
601472,Charcot–Marie–Tooth disease type 2D,GARS
607684,Charcot–Marie–Tooth disease type 2E,NEFL
607677,Charcot–Marie–Tooth disease type 2I,MPZ
607736,Charcot–Marie–Tooth disease type 2J,MPZ
214400,Charcot–Marie–Tooth disease type 4A,GDAP1
601382,Charcot–Marie–Tooth disease type 4B1,MTMR2
604563,Charcot–Marie–Tooth disease type 4B2,SBF2
601596,Charcot–Marie–Tooth disease type 4C,SH3TC2
601455,Charcot–Marie–Tooth disease type 4D,NDRG1
145900,Charcot–Marie–Tooth disease type 4F,PRX
609311,Charcot–Marie–Tooth disease type 4H,FGD4
611228,Charcot–Marie–Tooth disease type 4J,FIG4
311070,"Charcot–Marie–Tooth disease, X-linked recessive, 5",PRPS1
302800,"Charcot–Marie–Tooth neuropathy, X-linked dominant, 1",GJB1
214800,CHARGE syndrome,CHD7
214800,CHARGE syndrome,SEMA3E
214500,Chédiak–Higashi syndrome,CHS1
118400,Cherubism,SH3BP2
610448,Chilblain lupus,TREX1
308050,CHILD syndrome,NSDHL
214700,"Chloride diarrhea, congenital, Finnish type",SLC26A3
605479,"Cholestasis, benign recurrent intrahepatic, 2",ABCB11
243300,"Cholestasis, benign recurrent intrahepatic",ATP8B1
147480,"Cholestasis, familial intrahepatic, of pregnancy",ABCB4
211600,"Cholestasis, progressive familial intrahepatic 1",ATP8B1
601847,"Cholestasis, progressive familial intrahepatic 2",ABCB11
602347,"Cholestasis, progressive familial intrahepatic 3",ABCB4
607765,"Cholestasis, progressive familial intrahepatic 4",HSD3B7
278000,Cholesteryl ester storage disease,LIPA
118600,Chondrocalcinosis 2,ANKH
222765,"Chondrodysplasia punctata, rhizomelic, type 2",GNPAT
302960,"Chondrodysplasia punctata, X-linked dominant",EBP
302950,"Chondrodysplasia punctata, X-linked recessive",ARSE
215045,"Chondrodysplasia, Blomstrand type",PTHR1
200700,"Chondrodysplasia, Grebe type",GDF5
215300,Chondrosarcoma,EXT1
612237,"Chondrosarcoma, extraskeletal myxoid",TAF15
612237,"Chondrosarcoma, extraskeletal myxoid",TFG
612237,"Chondrosarcoma, extraskeletal myxoid",CSMF
118700,"Chorea, hereditary benign",NKX2-1
200150,Choreoacanthocytosis,VPS13A
610978,"Choreoathetosis, hypothyroidism, and neonatal respiratory distress",NKX2-1
613105,"Choriodal dystrophy, central areolar 2,",PRPH2
260500,Choroid plexus papilloma,TP53
303100,Choroideremia,CHM
606232,Chromosome 22q13.3 deletion syndrome,SHANK3
613443,Chromosome 5q14.3 deletion syndrome,MEF2C
609441,"Chrondrodysplasia, acromesomelic, with genital anomalies",BMPR1B
233700,Chronic granulomatous disease due to deficiency of NCF-1,NCF1
233710,Chronic granulomatous disease due to deficiency of NCF-2,NCF2
233690,"Chronic granulomatous disease, autosomal, due to deficiency of CYBA",CYBA
306400,"Chronic granulomatous disease, X-linked",CYBB
246700,Chylomicron retention disease,SAR1B
244400,"Ciliary dyskinesia, primary, 1, with or without situs inversus",DNAI1
612518,"Ciliary dyskinesia, primary, 10",KTU
612649,"Ciliary dyskinesia, primary, 11",RSPH4A
612650,"Ciliary dyskinesia, primary, 12",RSPH9
613193,"Ciliary dyskinesia, primary, 13",LRRC50
608644,"Ciliary dyskinesia, primary, 3, with or without situs inversus",DNAH5
610852,"Ciliary dyskinesia, primary, 6",TXNDC3
611884,"Ciliary dyskinesia, primary, 7, with or without situs inversus",DNAH11
612444,"Ciliary dyskinesia, primary, 9, with or without situs inversus",DNAI2
607115,CINCA syndrome,NLRP3
604901,"Cirrhosis, North American Indian childhood type",CIRH1A
215700,Citrullinemia,ASS1
603471,"Citrullinemia, adult-onset type II",SLC25A13
605814,"Citrullinemia, type II, neonatal-onset",SLC25A13
225060,Cleft lip/palate-ectodermal dysplasia syndrome,HVEC
119540,Cleft palate and mental retardation,SATB2
303400,Cleft palate with ankyloglossia,TBX22
119540,"Cleft palate, isolated",UBB
119600,Cleidocranial dysplasia,RUNX2
605039,C-like syndrome,CD96
609535,"Clopidogrel, impaired responsiveness to",CYP2C
119800,"Clubfoot, congenital",PITX1
216360,COACH syndrome,CC2D2A
216360,COACH syndrome,RPGRIP1L
216360,COACH syndrome,TMEM67
216400,Cockayne syndrome type A,ERCC8
133540,Cockayne syndrome type B,ERCC6
613630,Cocoon syndrome,CHUK
607426,Coenzyme Q10 deficiency,APTX
607426,Coenzyme Q10 deficiency,CABC1
607426,Coenzyme Q10 deficiency,COQ2
607426,Coenzyme Q10 deficiency,COQ9
607426,Coenzyme Q10 deficiency,PDSS1
607426,Coenzyme Q10 deficiency,PDSS2
303600,Coffin–Lowry syndrome,RPS6KA3
216550,Cohen syndrome,COH1
120100,"Cold-induced autoinflammatory syndrome, familial",NLRP3
610313,Cold-induced sweating syndrome 1,CLCF1
272430,Cold-induced sweating syndrome,CRLF1
120430,Coloboma of optic nerve,PAX6
120200,"Coloboma, ocular",PAX6
120200,"Coloboma, ocular",SHH
114500,"Colon cancer, somatic",PTPRJ
303800,"Colorblindness, deutan",OPN1MW
190900,"Colorblindness, tritan",OPN1SW
132600,"Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas",MUTYH
114500,Colorectal cancer,AXIN2
114500,Colorectal cancer,BUB1B
114500,Colorectal cancer,EP300
114500,Colorectal cancer,NRAS
114500,Colorectal cancer,PDGFRL
114500,Colorectal cancer,TP53
120435,"Colorectal cancer, hereditary nonpolyposis, type 1",MSH2
609310,"Colorectal cancer, hereditary nonpolyposis, type 2",MLH1
613244,"Colorectal cancer, hereditary nonpolyposis, type I",EPCAM
109800,"Colorectal cancer, somatic",FGFR3
114500,"Colorectal cancer, somatic",AKT1
114500,"Colorectal cancer, somatic",APC
114500,"Colorectal cancer, somatic",FLCN
114500,"Colorectal cancer, somatic",MLH3
114500,"Colorectal cancer, somatic",PIK3CA
233650,Combined cellular and humoral immune defects with granulomas,RAG1
233650,Combined cellular and humoral immune defects with granulomas,RAG2
227300,Combined factor V and VIII deficiency,LMAN1
144250,"Combined hyperlipidemia, familial",LPL
312863,"Combined immunodeficiency, X-linked, moderate",IL2RG
609060,Combined oxidative phosphorylation deficiency 1,GFM1
610498,Combined oxidative phosphorylation deficiency 2,MRPS16
610505,Combined oxidative phosphorylation deficiency 3,TSFM
610678,Combined oxidative phosphorylation deficiency 4,TUFM
611719,Combined oxidative phosphorylation deficiency 5,MRPS22
300816,Combined oxidative phosphorylation deficiency 6,AIFM1
611721,Combined SAP deficiency,PSAP
120790,"Complement component 4, partial deficiency of",C1NH
609814,Complement factor H deficiency,HF1
610984,Complement factor I deficiency,CFI
252010,"Complex I, mitochondrial respiratory chain, deficiency of",NDUFS6
613093,Cone dystrophy 4,PDE6C
602093,Cone dystrophy-3,GUCA1A
610283,Cone–rod dystrophy 10,SEMA4A
610381,Cone–rod dystrophy 11,RAXL1
612657,Cone–rod dystrophy 12,PROM1
608194,Cone–rod dystrophy 13,RPGRIP1
602093,Cone–rod dystrophy 14,GUCA1A
613660,Cone–rod dystrophy 15,CDHR1
604116,Cone–rod dystrophy 3,ABCA4
600977,Cone–rod dystrophy 5,PITPNM3
601777,Cone–rod dystrophy,GUCY2D
603649,Cone–rod dystrophy 7,RIMS1
612775,Cone–rod dystrophy 9,ADAM9
300476,"Cone–rod dystrophy, X-linked, 3",CACNA1F
304020,Cone–rod dystrophy-1,RPGR
120970,Cone–rod retinal dystrophy-2,CRX
277180,Congenital bilateral absence of vas deferens,CFTR
604168,"Congenital cataracts, facial dysmorphism, and neuropathy",CTDP1
212065,"Congenital disorder of glycosylation, type Ia",PMM2
603147,"Congenital disorder of glycosylation, type Ic",ALG6
601110,"Congenital disorder of glycosylation, type Id",ALG3
608799,"Congenital disorder of glycosylation, type Ie",DPM1
609180,"Congenital disorder of glycosylation, type If",MPDU1
607143,"Congenital disorder of glycosylation, type Ig",ALG12
608104,"Congenital disorder of glycosylation, type Ih",ALG8
607906,"Congenital disorder of glycosylation, type Ii",ALG2
212066,"Congenital disorder of glycosylation, type IIA",MGAT2
606056,"Congenital disorder of glycosylation, type IIb",GCS1
266265,Congenital disorder of glycosylation type IIc,SLC35C1
607091,"Congenital disorder of glycosylation, type IId",B4GALT1
608779,"Congenital disorder of glycosylation, type IIe",COG7
603585,"Congenital disorder of glycosylation, type IIf",SLC35A1
611209,"Congenital disorder of glycosylation, type IIg",COG1
611182,"Congenital disorder of glycosylation, type IIh",COG8
613489,"Congenital disorder of glycosylation, type IIj",COG4
608093,"Congenital disorder of glycosylation, type Ij",DPAGT2
608540,"Congenital disorder of glycosylation, type Ik",ALG1
608776,"Congenital disorder of glycosylation, type Il",ALG9
610768,"Congenital disorder of glycosylation, type Im",TMEM15
612015,"Congenital disorder of glycosylation, type In",RFT1
612937,"Congenital disorder of glycosylation, type Io",DPM3
612379,"Congenital disorder of glycosylation, type Ip",SRD5A3
306955,"Congenital heart defects, nonsyndromic, 1, X-linked",ZIC3
612863,"Congenital heart disease, nonsyndromic, 2",TAB2
217090,"Conjunctivitis, ligneous",PLG
217095,Conotruncal anomaly face syndrome,TBX1
121050,"Contractural arachnodactyly, congenital",FBN2
607745,"Convulsions, benign familial infantile, 3",SCN2A1
604352,"Convulsions, familial febrile, 4",GPR98
606963,"COPD, rate of decline of lung function in",MMP1
121300,Coproporphyria,CPOX
217300,"Cornea plana congenita, recessive",KERA
609140,"Corneal dystrophy polymorphous posterior, 2",COL8A2
607541,"Corneal dystrophy, Avellino type",TGFBI
610048,"Corneal dystrophy, congenital stromal",DCN
121800,"Corneal dystrophy, crystalline, of Schnyder",UBIAD1
121820,"Corneal dystrophy, epithelial basement membrane",TGFBI
136800,"Corneal dystrophy, Fuchs endothelial, 1",COL8A2
613268,"Corneal dystrophy, Fuchs endothelial, 4",SLC4A11
613270,"Corneal dystrophy, Fuchs endothelial, 6",ZEB1
204870,"Corneal dystrophy, gelatinous drop-like",TACSTD2
121900,"Corneal dystrophy, Groenouw type I",TGFBI
122000,"Corneal dystrophy, hereditary polymorphous posterior",VSX1
122200,"Corneal dystrophy, lattice type I",TGFBI
608471,"Corneal dystrophy, lattice type IIIA",TGFBI
609141,"Corneal dystrophy, posterior polymorphous, 3",ZEB1
608470,"Corneal dystrophy, Reis-Bucklers type",TGFBI
602082,"Corneal dystrophy, Thiel-Behnke type",TGFBI
217700,Corneal endothelial dystrophy 2,SLC4A11
217400,Corneal endothelial dystrophy and perceptive deafness,SLC4A11
121850,Corneal fleck dystrophy,PIKFYVE
122470,Cornelia de Lange syndrome 1,NIPBL
300590,Cornelia de Lange syndrome 2,DXS423E
610759,Cornelia de Lange syndrome 3,CSPG6
300472,"Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia",IGBP1
304100,"Corpus callosum, partial agenesis of",L1CAM
610042,Cortical dysplasia-focal epilepsy syndrome,CNTNAP2
611489,Corticosteroid-binding globulin deficiency,CBG
604931,Cortisone reductase deficiency,H6PD
604931,Cortisone reductase deficiency,HSD11B1
218040,Costello syndrome,HRAS
122700,Coumarin resistance,CYP2A6
260660,Cousin syndrome,TBX15
158350,Cowden syndrome,PTEN
612359,Cowden-like syndrome,SDHB
612359,Cowden-like syndrome,SDHD
255120,"CPT deficiency, hepatic, type IA",CPT1A
600649,"CPT deficiency, hepatic, type II",CPT2
608836,"CPT II deficiency, lethal neonatal",CPT2
218330,Cranioectodermal dysplasia,IFT122
122880,Craniofacial-deafness-hand syndrome,PAX3
304110,Craniofrontonasal dysplasia,EFNB1
607812,Cranio-lenticulo-sutural dysplasia,SEC23A
123000,Craniometaphyseal dysplasia,ANKH
259100,Cranioosteoarthropathy,HPGD
123100,"Craniosynostosis, type 1",TWIST1
604757,"Craniosynostosis, type 2",MSX2
303350,CRASH syndrome,L1CAM
300352,"Creatine deficiency syndrome, X-linked",SLC6A8
123320,"Creatine phosphokinase, elevated serum",CAV3
123400,Creutzfeldt–Jakob disease,PRNP
218800,Crigler–Najjar syndrome type I,UGT1A1
606785,Crigler–Najjar syndrome type II,UGT1A1
601378,Crisponi syndrome,CRLF1
612247,Crouzon syndrome with acanthosis nigricans,FGFR3
123500,Crouzon syndrome,FGFR2
219050,"Cryptorchidism, bilateral",LGR8
219050,"Cryptorchidism, idiopathic",INSL3
176450,Currarino syndrome,MNX1
613177,"Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities",LTBP4
123700,"Cutis laxa, AD",ELN
123700,"Cutis laxa, autosomal dominant",FBLN5
219100,"Cutis laxa, autosomal recessive",FBLN5
219100,"Cutis laxa, autosomal recessive, type I",EFEMP2
219200,"Cutis laxa, autosomal recessive, type II",ATP6V0A2
612940,"Cutis laxa, autosomal recessive, type IIB",PYCR1
219100,"Cutis laxa, recessive, type I",LOX
132700,"Cylindromatosis, familial",CYLD1
219500,Cystathioninuria,CTH
219700,Cystic fibrosis,CFTR
219900,"Cystinosis, late-onset juvenile or adolescent nephropathic",CTNS
219800,"Cystinosis, nephropathic",CTNS
219750,"Cystinosis, ocular nonnephropathic",CTNS
220100,Cystinuria,SLC3A1
220100,Cystinuria,SLC7A9
220110,Cytochrome C oxidase deficiency,COX6B1
600721,D-2-hydroxyglutaric aciduria,D2HGDH
220200,Dandy–Walker malformation,ZIC1
220200,Dandy–Walker malformation,ZIC4
124200,Darier disease,ATP2A2
612541,Darsun syndrome,G6PC3
261515,D-bifunctional protein deficiency,HSD17B4
256050,De la Chapelle dysplasia,SLC26A2
278800,De Sanctis–Cacchione syndrome,ERCC6
124900,"Deafness, autosomal dominant 1",DIAPH1
601316,"Deafness, autosomal dominant 10",EYA4
601317,"Deafness, autosomal dominant 11, neurosensory",MYO7A
601868,"Deafness, autosomal dominant 13",COL11A2
602459,"Deafness, autosomal dominant 15",POU4F3
603622,"Deafness, autosomal dominant 17",MYH9
604717,"Deafness, autosomal dominant 20/26",ACTG1
606346,"Deafness, autosomal dominant 22",MYO6
605192,"Deafness, autosomal dominant 23",SIX1
605583,"Deafness, autosomal dominant 25",SLC17A8
608641,"Deafness, autosomal dominant 28",GRHL2
600101,"Deafness, autosomal dominant 2A",KCNQ4
612644,"Deafness, autosomal dominant 2B",GJB3
606705,"Deafness, autosomal dominant 36",TMC1
605594,"Deafness, autosomal dominant 36, with dentinogenesis",DSPP
601544,"Deafness, autosomal dominant 3A",GJB2
612643,"Deafness, autosomal dominant 3B",GJB6
600652,"Deafness, autosomal dominant 4",MYH14
607453,"Deafness, autosomal dominant 44",CCDC50
607841,"Deafness, autosomal dominant 48",MYO1A
600994,"Deafness, autosomal dominant 5",DFNA5
613074,"Deafness, autosomal dominant 50",MIR96
601543,"Deafness, autosomal dominant 8/12",TECTA
601369,"Deafness, autosomal dominant 9",COCH
605316,"Deafness, autosomal recessive 10, congenital",TMPRSS3
601386,"Deafness, autosomal recessive 12",CDH23
603720,"Deafness, autosomal recessive 16",STRC
602092,"Deafness, autosomal recessive 18",USH1C
220290,"Deafness, autosomal recessive 1A",GJB2
612645,"Deafness, autosomal recessive 1B",GJB6
600060,"Deafness, autosomal recessive 2, neurosensory",MYO7A
603629,"Deafness, autosomal recessive 21",TECTA
607039,"Deafness, autosomal recessive 22",OTOA
609533,"Deafness, autosomal recessive 23",PCDH15
613285,"Deafness, autosomal recessive 25",GRXCR1
609823,"Deafness, autosomal recessive 28",TRIOBP
600316,"Deafness, autosomal recessive 3",MYO15A
607101,"Deafness, autosomal recessive 30",MYO3A
607084,"Deafness, autosomal recessive 31",WHRN
608565,"Deafness, autosomal recessive 35",ESRRB
609006,"Deafness, autosomal recessive 36",ESPN
607821,"Deafness, autosomal recessive 37",MYO6
608265,"Deafness, autosomal recessive 39",HGF
610153,"Deafness, autosomal recessive 49",MARVELD2
609706,"Deafness, autosomal recessive 53",COL11A2
610220,"Deafness, autosomal recessive 59",PJVK
600971,"Deafness, autosomal recessive 6",TMIE
611451,"Deafness, autosomal recessive 63",LRTOMT
610265,"Deafness, autosomal recessive 67",LHFPL5
600974,"Deafness, autosomal recessive 7",TMC1
613079,"Deafness, autosomal recessive 77",LOXHD1
613307,"Deafness, autosomal recessive 79",TPRN
601072,"Deafness, autosomal recessive 8, childhood onset",TMPRSS3
613391,"Deafness, autosomal recessive 84",PTPRQ
601071,"Deafness, autosomal recessive 9",OTOF
613453,"Deafness, autosomal recessive 91",SERPINB6
611022,"Deafness, autosomal recessive, 24",RDX
610706,"Deafness, congenital with inner ear agenesis, microtia, and microdontia",FGF3
220290,"Deafness, digenic GJB2/GJB6",GJB6
220290,"Deafness, digenic, GJB2/GJB3",GJB3
606346,"Deafness, sensorineural, with hypertrophic cardiomyopathy",MYO6
304500,"Deafness, X-linked 1",PRPS1
304400,"Deafness, X-linked 2",POU3F4
603528,"Dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema",PIEZO1
145900,Dejerine–Sottas disease,PMP22
145900,Dejerine–Sottas neuropathy,EGR2
145900,"Dejerine–Sottas neuropathy, autosomal recessive",PRX
145900,Dejerine–Sottas syndrome,MPZ
176500,"Dementia, familial British",ITM2B
117300,"Dementia, familial Danish",ITM2B
600795,"Dementia, familial, nonspecific",CHMP2B
600274,"Dementia, frontotemporal",PSEN1
600274,"Dementia, frontotemporal, with or without parkinsonism",MAPT
127750,"Dementia, Lewy body",SNCA
127750,"Dementia, Lewy body",SNCB
300555,Dent's disease 2,OCRL
300009,Dent's disease,CLCN5
125370,Dentatorubr–pallidoluysian atrophy,ATN1
125420,"Dentin dysplasia, type II",DSPP
125490,"Dentinogenesis imperfecta, Shields type II",DSPP
125500,"Dentinogenesis imperfecta, Shields type III",DSPP
194080,Denys–Drash syndrome,WT1
125595,Dermatopathia pigmentosa reticularis,KRT14
251450,Desbuquois dysplasia,CANT1
135290,"Desmoid disease, hereditary",APC
602398,Desmosterolosis,DHCR24
125800,"Diabetes insipidus, nephrogenic",AQP2
304800,"Diabetes insipidus, nephrogenic",AVPR2
125700,"Diabetes insipidus, neurohypophyseal",AVP
125851,"Diabetes mellitus, gestational",GCK
125852,"Diabetes mellitus, insulin-dependent, 2",INS
612520,"Diabetes mellitus, insulin-dependent, 20",HNF1A
610549,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans",INSR
612227,"Diabetes mellitus, ketosis-prone",PAX4
610199,"Diabetes mellitus, neonatal, with congenital hypothyroidism",GLIS3
125853,"Diabetes mellitus, noninsulin-dependent",ABCC8
125853,"Diabetes mellitus, noninsulin-dependent",HNF1B
125853,"Diabetes mellitus, noninsulin-dependent, late onset",GCK
606176,"Diabetes mellitus, permanent neonatal",ABCC8
606176,"Diabetes mellitus, permanent neonatal",GCK
606176,"Diabetes mellitus, permanent neonatal",INS
609069,"Diabetes mellitus, permanent neonatal, with cerebellar agenesis",PTF1A
606176,"Diabetes mellitus, permanent neonatal, with neurologic features",KCNJ11
610374,"Diabetes mellitus, transient neonatal 2",ABCC8
601410,"Diabetes mellitus, transient neonatal, 1",ZFP57
610582,"Diabetes mellitus, transient neonatal, 3",KCNJ11
125852,"Diabetes mellitus, type 1",INS
125853,"Diabetes mellitus, type 2",PAX4
125853,Diabetes mellitus type II,AKT2
606176,"Diabetes, permanent neonatal",KCNJ11
105650,Diamond–Blackfan anemia 1,RPS19
613309,Diamond–Blackfan anemia 10,RPS26
612527,Diamond-Blackfan anemia 4,RPS17
612528,Diamond–Blackfan anemia 5,RPL35A
612561,Diamond–Blackfan anemia 6,RPL5
612562,Diamond–Blackfan anemia 7,RPL11
612563,Diamond–Blackfan anemia 8,RPS7
613308,Diamond–Blackfan anemia 9,RPS10
610629,Diamond–Blackfan anemia,RPS24
610187,Diaphragmatic hernia 3,ZFPM2
270420,"Diarrhea 3, secretory sodium, congenital, syndromic",SPINT2
610370,"Diarrhea 4, malabsorptive, congenital",NEUROG3
613217,"Diarrhea 5, with tufting enteropathy, congenital",EPCAM
222600,Diastrophic dysplasia,SLC26A2
222600,"Diastrophic dysplasia, broad bone-platyspondylic variant",SLC26A2
222730,Dicarboxylic aminoaciduria,SLC1A1
188400,DiGeorge syndrome,TBX1
119900,"Digital clubbing, isolated congenital",HPGD
274270,Dihydropyrimidine dehydrogenase deficiency,DPYD
222748,Dihydropyrimidinuria,DPYS
605676,Dilated cardiomyopathy with woolly hair and keratoderma,DSP
605850,Dimethylglycine dehydrogenase deficiency,DMGDH
201750,"Disordered steroidogenesis, isolated",POR
222448,Donnai–Barrow syndrome,LRP2
223360,Dopamine beta-hydroxylase deficiency,DBH
300018,Dosage-sensitive sex reversal,DAX1
217095,Double outlet right ventricle,CFC1
217095,Double outlet right ventricle,GDF1
179850,Dowling–Degos disease,KRT5
126600,Doyne honeycomb degeneration of retina,EFEMP1
607208,Dravet syndrome,SCN1A
604356,Duane retraction syndrome 2,CHN1
607323,Duane-radial ray syndrome,SALL4
237500,Dubin–Johnson syndrome,ABCC2
310200,Duchenne muscular dystrophy,DMD
223800,Dyggve–Melchior–Clausen disease,DYM
223900,"Dysautonomia, familial",IKBKAP
127400,Dyschromatosis symmetrica hereditaria,ADAR
300367,Dyserythropoietic anemia with thrombocytopenia,GATA1
127550,Dyskeratosis congenita,TERT
224230,Dyskeratosis congenita,NOLA2
127550,"Dyskeratosis congenita, autosomal dominant",TERC
127550,"Dyskeratosis congenita, autosomal dominant",TINF2
224230,"Dyskeratosis congenita, autosomal recessive",NOLA3
305000,Dyskeratosis congenita-1,DKC1
224410,"Dyssegmental dysplasia, Silverman-Handmaker type",HSPG2
612067,Dystonia 16,PRKRA
602629,"Dystonia 6, torsion",THAP1
612716,"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency",SPR
233910,"Dystonia, DOPA-responsive, with or without hyperphenylalainemia",GCH1
607371,"Dystonia, juvenile-onset",ACTB
159900,"Dystonia, myoclonic",DRD2
128100,"Dystonia-1, torsion",DYT1
159900,"Dystonia-11, myoclonic",SGCE
128235,Dystonia-12,ATP1A3
612953,"Dystonia-parkinsonism, adult-onset",PLA2G6
314250,"Dystonia-Parkinsonism, X-linked",TAF1
226600,EBD inversa,COL7A1
132000,"EBD, Bart type",COL7A1
129490,"Ectodermal dysplasia, anhidrotic, autosomal dominant",EDARADD
224900,"Ectodermal dysplasia, anhidrotic, autosomal recessive",EDARADD
612132,"Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency",NFKBIA
305100,"Ectodermal dysplasia, anhidrotic, X-linked",ED1
225280,"Ectodermal dysplasia, ectrodactyly, and macular dystrophy",CDH3
129500,"Ectodermal dysplasia, hidrotic",GJB6
129490,"Ectodermal dysplasia, hypohidrotic, autosomal dominant",EDAR
224900,"Ectodermal dysplasia, hypohidrotic, autosomal recessive",EDAR
300291,"Ectodermal dysplasia, hypohidrotic, with immune deficiency",IKBKG
602032,"Ectodermal dysplasia, 'pure' hair-nail type",KRT85
604536,Ectodermal dysplasia-skin fragility syndrome,PKP1
613573,Ectodermal dysplasia-syndactyly syndrome 1,PVRL4
300301,"Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency",IKBKG
129600,"Ectopia lentis, familial",FBN1
225100,"Ectopia lentis, isolated, autosomal recessive",ADAMTSL4
604292,"Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3",TP63
606408,Ehlers–Danlos due to tenascin X deficiency,TNXB
225320,"Ehlers–Danlos syndrome, cardiac valvular form",COL1A2
130020,"Ehlers–Danlos syndrome, hypermobility type",TNXB
601776,"Ehlers-Danlos syndrome, musculocontractural type",CHST14
130070,"Ehlers–Danlos syndrome, progeroid form",B4GALT7
130000,"Ehlers–Danlos syndrome, type I",COL1A1
130000,"Ehlers–Danlos syndrome, type I",COL5A1
130000,"Ehlers–Danlos syndrome, type I",COL5A2
130010,"Ehlers–Danlos syndrome, type II",COL5A1
130020,"Ehlers–Danlos syndrome, type III",COL3A1
130050,"Ehlers–Danlos syndrome, type IV",COL3A1
225400,"Ehlers–Danlos syndrome, type VI",PLOD
130060,"Ehlers–Danlos syndrome, type VIIA",COL1A1
130060,"Ehlers–Danlos syndrome, type VIIB",COL1A2
225410,"Ehlers–Danlos syndrome, type VIIC",ADAMTS2
600002,Eiken syndrome,PTHR1
611804,Elliptocytosis-1,EPB41
130600,Elliptocytosis-2,SPTA1
225500,Ellis–van Creveld syndrome,EVC
225500,Ellis–van Creveld syndrome,LBN
612998,Emery–Dreifuss muscular dystrophy 4,SYNE1
612999,Emery–Dreifuss muscular dystrophy 5,SYNE2
300696,Emery–Dreifuss muscular dystrophy 6,FHL1
310300,Emery–Dreifuss muscular dystrophy,EMD
181350,"Emery–Dreifuss muscular dystrophy, AD",LMNA
181350,"Emery–Dreifuss muscular dystrophy, AR",LMNA
613490,Emphysema due to AAT deficiency,SERPINA1
613490,"Emphysema-cirrhosis, due to AAT deficiency",SERPINA1
604273,"Encephalocardiomyopathy, neonatal, mitochondrial, due to ATP synthase deficiency",TMEM70
604218,"Encephalopathy, familial, with neuroserpin inclusion bodies",SERPINI1
300673,"Encephalopathy, neonatal severe",MECP2
612651,Endocrine-cerebroosteodysplasia,ICK
608089,Endometrial cancer,MLH3
608089,"Endometrial cancer, familial",MSH6
603034,Endplate acetylcholinesterase deficiency,COLQ
268100,Enhanced S-cone syndrome,NR2E3
600791,Enlarged vestibular aqueduct,FOXI1
600791,Enlarged vestibular aqueduct,SLC26A4
226200,Enterokinase deficiency,PRSS7
261500,Eosinophil peroxidase deficiency,EPX
226400,Epidermodysplasia verruciformis,TMC6
226400,Epidermodysplasia verruciformis,TMC8
131750,"Epidermolysis bullosa dystrophica, AD",COL7A1
226600,"Epidermolysis bullosa dystrophica, AR",COL7A1
131800,Epidermolysis bullosa of hands and feet,ITGB4
604129,Epidermolysis bullosa pruriginosa,COL7A1
609352,Epidermolysis bullosa simplex with migratory circinate erythema,KRT5
131960,Epidermolysis bullosa simplex with mottled pigmentation,KRT5
612138,Epidermolysis bullosa simplex with pyloric atresia,PLEC1
131760,"Epidermolysis bullosa simplex, Dowling-Meara type",KRT14
131760,"Epidermolysis bullosa simplex, Dowling-Meara type",KRT5
131900,"Epidermolysis bullosa simplex, Koebner type",KRT14
131900,"Epidermolysis bullosa simplex, Koebner type",KRT5
131950,"Epidermolysis bullosa simplex, Ogna type",PLEC1
601001,"Epidermolysis bullosa simplex, recessive",KRT14
131800,"Epidermolysis bullosa simplex, Weber-Cockayne type",KRT14
131800,"Epidermolysis bullosa simplex, Weber-Cockayne type",KRT5
226650,"Epidermolysis bullosa, generalized atrophic benign",LAMA3
226700,"Epidermolysis bullosa, junctional, Herlitz type",LAMA3
226700,"Epidermolysis bullosa, junctional, Herlitz type",LAMB3
226700,"Epidermolysis bullosa, junctional, Herlitz type",LAMC2
226650,"Epidermolysis bullosa, junctional, non-Herlitz type",COL17A1
226650,"Epidermolysis bullosa, junctional, non-Herlitz type",ITGB4
226650,"Epidermolysis bullosa, junctional, non-Herlitz type",LAMB3
226650,"Epidermolysis bullosa, junctional, non-Herlitz type",LAMC2
226730,"Epidermolysis bullosa, junctional, with pyloric atresia",ITGB4
226730,"Epidermolysis bullosa, junctional, with pyloric stenosis",ITGA6
609638,"Epidermolysis bullosa, lethal acantholytic",DSP
131850,"Epidermolysis bullosa, pretibial",COL7A1
113800,Epidermolytic hyperkeratosis,KRT1
113800,Epidermolytic hyperkeratosis,KRT10
144200,Epidermolytic palmoplantar keratoderma,KRT9
121201,"Epilepsy, benign neonatal, type 2",KCNQ3
121200,"Epilepsy, benign, neonatal, type 1",KCNQ2
300088,"Epilepsy, female-restricted, with mental retardation",PCDH19
604233,"Epilepsy, generalized, with febrile seizures plus, type 2",SCN1A
604233,"Epilepsy, generalized, with febrile seizures plus, type 3",GABRG2
613060,"Epilepsy, juvenile myoclonic, susceptibility to",GABRD
254780,"Epilepsy, myoclonic, Lafora type",EPM2A
254780,"Epilepsy, myoclonic, Lafora type",NHLRC1
300432,"Epilepsy, myoclonic, with mental retardation and spasticity",ARX
609304,"Epilepsy, neonatal myoclonic, with suppression-burst pattern",SLC25A22
600513,"Epilepsy, nocturnal frontal lobe, 1",CHRNA4
605375,"Epilepsy, nocturnal frontal lobe, 3",CHRNB2
610353,"Epilepsy, nocturnal frontal lobe, type 4",CHRNA2
600512,"Epilepsy, partial, with auditory features",LGI1
254800,"Epilepsy, progressive myoclonic 1",CSTB
612437,"Epilepsy, progressive myoclonic 1B",PRICKLE1
254780,"Epilepsy, progressive myoclonic 2B",NHLRC1
611726,"Epilepsy, progressive myoclonic 3",KCTD7
266100,"Epilepsy, pyridoxine-dependent",ALDH7A1
607208,"Epilepsy, severe myoclonic, of infancy",SCN1A
300491,"Epilepsy, X-linked, with variable learning disabilities and behavior disorders",SYN1
308350,"Epileptic encephalopathy, early infantile, 1",ARX
300672,"Epileptic encephalopathy, early infantile, 2",CDKL5
612164,"Epileptic encephalopathy, early infantile, 4",STXBP1
613477,"Epileptic encephalopathy, early infantile, 5",SPTAN1
606369,"Epileptic encephalopathy, Lennox-Gastaut type",MAPK10
132400,"Epiphyseal dysplasia, multiple 1",COMP
600204,"Epiphyseal dysplasia, multiple, 2",COL9A2
600969,"Epiphyseal dysplasia, multiple, 3",COL9A3
226900,"Epiphyseal dysplasia, multiple, 4",SLC26A2
607078,"Epiphyseal dysplasia, multiple, 5",MATN3
132450,"Epiphyseal dysplasia, multiple, with myopia and deafness",COL2A1
108500,"Episodic ataxia, type 2",CACNA1A
612656,"Episodic ataxia, type 6",SLC1A3
160120,Episodic ataxia/myokymia syndrome,KCNA1
153650,Epstein syndrome,MYH9
133020,"Erythermalgia, primary",SCN9A
245340,Erythrocyte lactate transporter defect,SLC16A1
609820,"Erythrocytosis, familial, 3",EGLN1
611783,"Erythrocytosis, familial, 4",EPAS1
133200,Erythrokeratodermia variabilis et progressiva,GJB3
133200,Erythrokeratodermia variabilis with erythema gyratum repens,GJB4
265000,Escobar syndrome,CHRNG
133239,Esophageal cancer,DLEC1
133239,"Esophageal cancer, somatic",TGFBR2
133239,"Esophageal carcinoma, somatic",RNF6
133239,Esophageal squamous cell carcinoma,40513
133239,Esophageal squamous cell carcinoma,LZTS1
133239,Esophageal squamous cell carcinoma,WWOX
602473,Ethylmalonic encephalopathy,ETHE1
612219,Ewing sarcoma,EWSR1
612714,"Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis",COX4I2
133700,"Exostoses, multiple, type 1",EXT1
133701,"Exostoses, multiple, type 2",EXT2
601813,Exudative vitreoretinopathy 4,LRP5
613310,Exudative vitreoretinopathy 5,TSPAN12
133780,Exudative vitreoretinopathy,FZD4
305390,"Exudative vitreoretinopathy, X-linked",NDP
301500,Fabry disease,GLA
301500,"Fabry disease, cardiac variant",GLA
227300,"Factor V and factor VIII, combined deficiency of",MCFD2
227400,Factor V deficiency,F5
612416,"Factor XI deficiency, autosomal dominant",F11
612416,"Factor XI deficiency, autosomal recessive",F11
234000,Factor XII deficiency,F12
613225,Factor XIIIA deficiency,F13A1
613235,Factor XIIIB deficiency,F13B
125350,"Failure of tooth eruption, primary",PTHR1
611762,Familial cold autoinflammatory syndrome 2,NALP12
134610,"Familial Mediterranean fever, AD",MEFV
249100,"Familial Mediterranean fever, AR",MEFV
613390,"Fanconi anemia, complementation group 0",RAD51C
227650,"Fanconi anemia, complementation group A",FANCA
300514,"Fanconi anemia, complementation group B",FAAP95
605724,"Fanconi anemia, complementation group D1",BRCA2
609053,"Fanconi anemia, complementation group I",FANCI
609054,"Fanconi anemia, complementation group J",BRIP1
610832,"Fanconi anemia, complementation group N",PALB2
613388,Fanconi renotubular syndrome 2,SLC34A1
227810,Fanconi–Bickel syndrome,SLC2A2
228000,Farber lipogranulomatosis,ASAH1
609016,"Fatty liver, acute, of pregnancy",HADHA
604403,"Febrile convulsions, familial, 3A",SCN1A
604403,"Febrile convulsions, familial, 3B",SCN9A
611277,"Febrilel, convulsions, familial",GABRG2
153640,Fechtner syndrome,MYH9
164280,Feingold syndrome,MYCN
228300,Fertile eunuch syndrome,GNRHR
208150,Fetal akinesia deformation sequence,DOK7
208150,Fetal akinesia deformation sequence,RAPSN
141749,Fetal hemoglobin quantitative trait locus 1,HBG1
141749,Fetal hemoglobin quantitative trait locus 1,HBG2
300321,FG syndrome 2,FLNA
300422,FG syndrome 4,CASK
135100,Fibrodysplasia ossificans progressiva,ACVR1
135300,"Fibromatosis, gingival",SOS1
135300,"Fibromatosis, gingival, 2",GINGF2
228600,"Fibromatosis, juvenile hyaline",ANTXR2
135700,"Fibrosis of extraocular muscles, congenital, 1",KIF21A
602078,"Fibrosis of extraocular muscles, congenital, 2",PHOX2A
600638,"Fibrosis of extraocular muscles, congenital, 3A",TUBB3
135700,"Fibrosis of extraocular muscles, congenital, 3B",KIF21A
228900,Fibular hypoplasia and complex brachydactyly,GDF5
136120,Fish-eye disease,LCAT
612423,Fletcher factor deficiency,KLKB1
607341,"Focal cortical dysplasia, Taylor balloon cell type",TSC1
305600,Focal dermal hypoplasia,PORCN
229050,"Folate malabsorption, hereditary",SLC46A1
229070,"Follicle-stimulating hormone deficiency, isolated",FSHB
136520,Foveal hyperplasia,PAX6
608161,"Foveomacular dystrophy, adult-onset, with choroidal neovascularization",PRPH2
300624,Fragile X syndrome,FMR1
300623,Fragile X tremor/ataxia syndrome,FMR1
249420,Frank–ter Haar syndrome,SH3PXD2B
219000,Fraser syndrome,FRAS1
219000,Fraser syndrome,FREM2
136680,Frasier syndrome,WT1
229300,Friedreich's ataxia with retained reflexes,FXN
229300,Friedreich's ataxia,FXN
305620,Frontometaphyseal dysplasia,FLNA
613451,Frontonasal dysplasia 2,ALX4
613456,Frontonasal dysplasia 3,ALX1
136760,Frontorhiny,ALX3
607485,Frontotemporal lobar degeneration with ubiquitin-positive inclusions,GRN
612069,"Frontotemporal lobar degeneration, TARDBP-related",TARDBP
229600,Fructose intolerance,ALDOB
229700,"Fructose-1,6-bisphosphatase deficiency",FBP1
230000,Fucosidosis,FUCA1
228930,Fuhrmann syndrome,WNT7A
606812,Fumarase deficiency,FH
136880,Fundus albipunctatus,RDH5
136880,Fundus albipunctatus,RLBP1
248200,Fundus flavimaculatus,ABCA4
613163,GABA-transaminase deficiency,ABAT
230200,Galactokinase deficiency with cataracts,GALK1
230350,Galactose epimerase deficiency,GALE
230400,Galactosemia,GALT
256540,Galactosialidosis,CTSA
600803,Gallbladder disease 1,ABCB4
611465,Gallbladder disease 4,ABCG8
612736,GAMT deficiency,GAMT
137215,"Gastric cancer, familial diffuse",CDH1
137215,"Gastric cancer, somatic",APC
137215,"Gastric cancer, somatic",CASP10
137215,"Gastric cancer, somatic",ERBB2
137215,"Gastric cancer, somatic",FGFR2
137215,"Gastric cancer, somatic",IRF1
137215,"Gastric cancer, somatic",KLF6
137215,"Gastric cancer, somatic",MUTYH
137215,"Gastric cancer, somatic",PIK3CA
606764,"Gastrointestinal stromal tumor, somatic",KIT
606764,"Gastrointestinal stromal tumor, somatic",PDGFRA
610539,"Gaucher disease, atypical",PSAP
608013,"Gaucher disease, perinatal lethal",GBA
230800,"Gaucher disease, type",GBA
230900,"Gaucher disease, type II",GBA
231000,"Gaucher disease, type III",GBA
231005,"Gaucher disease, type IIIC",GBA
607313,"Gaze palsy, horizontal, with progressive scoliosis",ROBO3
231050,Geleophysic dysplasia,ADAMTSL2
609446,Generalized epilepsy and paroxysmal dyskinesia,KCNMA1
604233,Generalized epilepsy with febrile seizures plus,SCN1B
273300,Germ cell tumors,KIT
231070,Geroderma osteodysplasticum,SCYL1BP1
137440,Gerstmann–Sträussler–Scheinker syndrome,PRNP
231095,Ghosal syndrome,TBXAS1
256850,Giant axonal neuropathy-1,GAN
206700,Gillespie syndrome,PAX6
263800,Gitelman syndrome,SLC12A3
273800,"Glanzmann thrombasthenia, type A",ITGA2B
613100,"Glaucoma 1, open angle, 1O",NTF4
137760,"Glaucoma 1, open angle, E",OPTN
609887,"Glaucoma 1, open angle, G",WDR36
137750,"Glaucoma 1A, primary open angle, juvenile-onset",MYOC
137760,"Glaucoma 1B, primary open angle, adult onset",GLC1B
613086,"Glaucoma 3, primary congenital, D",LTBP2
231300,"Glaucoma 3A, primary congenital",CYP1B1
137760,"Glaucoma, primary open angle, adult-onset",CYP1B1
137750,"Glaucoma, primary open angle, juvenile-onset",CYP1B1
137800,"Glioblastoma, somatic",ERBB2
102530,Globozoospermia,GOPC
102530,Globozoospermia,SPATA16
609886,Glomerulocystic kidney disease with hyperuricemia and isosthenuria,UMOD
601894,Glomerulopathy with fibronectin deposits 2,FN1
603278,"Glomerulosclerosis, focal segmental, 1",ACTN4
603965,"Glomerulosclerosis, focal segmental, 2",TRPC6
607832,"Glomerulosclerosis, focal segmental, 3",CD2AP
613237,"Glomerulosclerosis, focal segmental, 5",INF2
138000,Glomuvenous malformations,GLML
607398,Glucocorticoid deficiency 2,MRAP
202200,"Glucocorticoid deficiency, due to ACTH unresponsiveness",MC2R
606824,Glucose-galactose malabsorption,SLC5A1
606777,GLUT1 deficiency syndrome 1,SLC2A1
612126,GLUT1 deficiency syndrome 2,SLC2A1
229100,Glutamate formiminotransferase deficiency,FTCD
610015,"Glutamine deficiency, congenital",GLUL
231670,"Glutaricaciduria, type I",GCDH
231680,"Glutaricaciduria, type IIA",ETFA
231680,"Glutaricaciduria, type IIB",ETFB
231680,"Glutaricaciduria, type IIC",ETFDH
266130,Glutathione synthetase deficiency,GSS
307030,Glycerol kinase deficiency,GK
605899,Glycine encephalopathy,AMT
605899,Glycine encephalopathy,GCSH
605899,Glycine encephalopathy,GLDC
606664,Glycine N-methyltransferase deficiency,GNMT
611556,"Glycogen storage disease 0, muscle",GYS1
232220,Glycogen storage disease Ib,SLC37A4
232240,Glycogen storage disease Ic,SLC37A4
232240,Glycogen storage disease Ic,SLC17A3
232300,Glycogen storage disease II,GAA
300257,Glycogen storage disease IIb,LAMP2
232400,Glycogen storage disease IIIa,AGL
232400,Glycogen storage disease IIIb,AGL
232500,Glycogen storage disease IV,GBE1
613027,Glycogen storage disease IXc,PHKG2
261740,"Glycogen storage disease of heart, lethal congenital",PRKAG2
232800,Glycogen storage disease VII,PFKM
261670,Glycogen storage disease X,PGAM2
612933,Glycogen storage disease XI,LDHA
611881,Glycogen storage disease XII,ALDOA
612932,Glycogen storage disease XIII,ENO3
612934,Glycogen storage disease XIV,PGM1
613507,Glycogen storage disease XV,GYG1
240600,Glycogen storage disease type 0,GYS2
306000,"Glycogen storage disease, type IXa1",PHKA2
306000,"Glycogen storage disease, type IXa2",PHKA2
610293,Glycosylphosphatidylinositol deficiency,PIGM
230500,"GM1-gangliosidosis, type I",GLB1
230600,"GM1-gangliosidosis, type II",GLB1
230650,"GM1-gangliosidosis, type III",GLB1
272750,"GM2-gangliosidosis, AB variant",GM2A
272800,"GM2-gangliosidosis, several forms",HEXA
166260,Gnathodiaphyseal dysplasia,ANO5
609460,Goldberg–Shpritzen megacolon syndrome,KIAA1279
300661,"Gout, PRPS-related",PRPS1
603358,GRACILE syndrome,BCS1L
215140,Greenberg dysplasia,LBR
175700,Greig cephalopolysyndactyly syndrome,GLI3
214450,Griscelli syndrome type 1,MYO5A
607624,Griscelli syndrome type 2,RAB27A
609227,Griscelli syndrome type 3,MLPH
182230,Growth hormone deficiency with pituitary anomalies,HESX1
262400,"Growth hormone deficiency, isolated, type IA",GH1
612781,"Growth hormone deficiency, isolated, type IB",GH1
612781,"Growth hormone deficiency, isolated, type IB",GHRHR
173100,"Growth hormone deficiency, isolated, type II",GH1
245590,Growth hormone insensitivity with immunodeficiency,STAT5B
608747,Growth retardation with deafness and mental retardation due to IGF1 deficiency,IGF1
612938,"Growth retardation, developmental delay, coarse facies, and early death",FTO
176305,Guttmacher syndrome,HOXA13
258870,Gyrate atrophy of choroid and retina with or without ornithinemia,OAT
209880,Haddad syndrome,ASCL1
169600,Hailey–Hailey disease,ATP2C1
245010,Haim–Munk syndrome,CTSC
234100,Hallermann–Streiff syndrome,GJA1
140000,Hand-foot-uterus Syndrome,HOXA13
121300,Harderoporphyria,CPOX
607236,HARP syndrome,PANK2
234500,Hartnup disorder,SLC6A19
140350,Hawkinsinuria,HPD
106260,Hay–Wells syndrome,TP63
604091,"HDL deficiency, type 2",ABCA1
600965,"Hearing loss, low-frequency sensorineural",WFS1
113900,"Heart block, nonprogressive",SCN5A
113900,"Heart block, progressive, type IA",SCN5A
140700,Heinz body anemia,HBA2
140700,"Heinz body anemias, alpha-",HBA1
140700,"Heinz body anemias, beta-",HBB
609016,"HELLP syndrome, maternal, of pregnancy",HADHA
602089,"Hemangioma, capillary infantile, somatic",FLT4
602089,"Hemangioma, capillary infantile, somatic",KDR
162800,"Hematopoiesis, cyclic",ELANE
141200,"Hematuria, benign familial",COL4A3
141500,"Hemiplegic migraine, familial",CACNA1A
602390,"Hemochromatosis, type 2A",HJV
613313,"Hemochromatosis, type 2B",HAMP
604250,"Hemochromatosis, type 3",TFR2
606069,"Hemochromatosis, type 4",SLC40A1
612631,Hemolytic anemia due to adenylate kinase deficiency,AK1
230450,Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency,GCLC
231900,Hemolytic anemia due to glutathione synthetase deficiency,GSS
235700,Hemolytic anemia due to hexokinase deficiency,HK1
613470,"Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency",GPI
235400,"Hemolytic uremic syndrome, atypical, susceptibility to, 1",HF1
603553,"Hemophagocytic lymphohistiocytosis, familial, 2",PRF1
608898,"Hemophagocytic lymphohistiocytosis, familial, 3",UNC13D
603552,"Hemophagocytic lymphohistiocytosis, familial, 4",STX11
306900,Hemophilia B,F9
613490,Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh,SERPINA1
604290,"Hemosiderosis, systemic, due to aceruloplasminemia",CP
235510,Hennekam lymphangiectasia-lymphedema syndrome,CCBE1
142330,Hepatic adenoma,HNF1A
235550,Hepatic venoocclusive disease with immunodeficiency,SP110
114550,Hepatocellular cancer,PDGFRL
114550,Hepatocellular carcinoma,CTNNB1
114550,Hepatocellular carcinoma,TP53
114550,"Hepatocellular carcinoma, childhood type",MET
114550,"Hepatocellular carcinoma, somatic",AXIN1
114550,"Hepatocellular carcinoma, somatic",CASP8
114550,"Hepatocellular carcinoma, somatic",PIK3CA
187300,Hereditary hemorrhagic telangiectasia-1,ENG
600376,Hereditary hemorrhagic telangiectasia-2,ACVRL1
601152,Hereditary motor and sensory neuropathy VI,MFN2
606071,"Hereditary motor and sensory neuropathy, type IIc",TRPV4
203300,Hermansky–Pudlak syndrome 1,HPS1
608233,Hermansky–Pudlak syndrome 2,AP3B1
203300,Hermansky–Pudlak syndrome 3,HPS3
203300,Hermansky–Pudlak syndrome 4,HPS4
203300,Hermansky–Pudlak syndrome 5,HPS5
203300,Hermansky–Pudlak syndrome 6,HPS6
203300,Hermansky–Pudlak syndrome 7,DTNBP1
203300,Hermansky–Pudlak syndrome 8,BLOC1S3
306955,"Heterotaxy, visceral, 1, S-linke",ZIC3
605376,"Heterotaxy, visceral, 2, autosomal",CFC1
270100,"Heterotaxy, visceral, 5",NODAL
300049,"Heterotopia, periventricular",FLNA
300537,"Heterotopia, periventricular, ED variant",FLNA
142623,Hirschsprung's disease,GDNF
142623,Hirschsprung's disease,RET
142623,"Hirschsprung disease, short-segment",PMX2B
612160,"Histiocytoma, angiomatoid fibrous, somatic",CREB1
605911,HMG-CoA synthase-2 deficiency,HMGCS2
236000,Hodgkin's lymphoma,KLHDC8B
253270,Holocarboxylase synthetase deficiency,HLCS
157170,Holoprosencephaly-2,SIX3
142945,Holoprosencephaly-3,SHH
142946,Holoprosencephaly-4,TGIF
609637,Holoprosencephaly-5,ZIC2
610828,Holoprosencephaly-7,PTCH1
610829,Holoprosencephaly-9,GLI2
142900,Holt-Oram syndrome,TBX5
236250,Homocystinuria due to MTHFR deficiency,MTHFR
236200,"Homocystinuria, B6-responsive and nonresponsive types",CBS
277410,"Homocystinuria, cblD type, variant 1",C2orf25
236270,"Homocystinuria-megaloblastic anemia, cbl E type",MTRR
300240,Hoyeraal-Hreidarsson syndrome,DKC1
300323,HPRT-related gout,HPRT1
143100,Huntington's disease,HTT
603218,Huntington disease-like 1,PRNP
606438,Huntington disease-like 2,JPH3
176670,Hutchinson–Gilford progeria syndrome,LMNA
236490,"Hyalinosis, infantile systemic",ANTXR2
231090,Hydatidiform mole,NALP7
300215,Hydranencephaly with abnormal genitalia,ARX
307000,Hydrocephalus due to aqueductal stenosis,L1CAM
307000,Hydrocephalus with congenital idiopathic intestinal pseudoobstruction,L1CAM
142623,Hydrocephalus with Hirschsprung disease and cleft palate,L1CAM
236680,Hydrolethalus syndrome,HYLS1
143470,Hyperalphalipoproteinemia,CETP
237900,"Hyperbilirubinemia, familial transcient neonatal",UGT1A1
115300,"Hypercarotenemia and vitamin A deficiency, autosomal dominant",BCMO1
607748,"Hypercholanemia, familial",BAAT
607748,"Hypercholanemia, familial",EPHX1
607748,"Hypercholanemia, familial",TJP2
144010,"Hypercholesterolemia, due to ligand-defective apo B",APOB
143890,"Hypercholesterolemia, familial",LDLR
603776,"Hypercholesterolemia, familial, 3",PCSK9
603813,"Hypercholesterolemia, familial, autosomal recessive",LDLRAP1
143890,"Hypercholesterolemia, familial, modification of",APOA2
144650,"Hyperchylomicronemia, late-onset",APOA5
300607,Hyperekplexia and epilepsy,ARHGEF9
149400,Hyperekplexia,GPHN
149400,Hyperekplexia,SLC6A5
149400,"Hyperekplexia, autosomal recessive",GLRB
607685,"Hypereosinophilic syndrome, idiopathic, resistant to imatinib",PDGFRA
600886,Hyperferritinemia-cataract syndrome,FTL
612348,"Hyperfibrinolysis, familial, due to increased release of PLAT",PLAT
138500,Hyperglycinuria,SLC36A2
138500,Hyperglycinuria,SLC6A19
138500,Hyperglycinuria,SLC6A20
260920,Hyper-IgD syndrome,MVK
147060,Hyper-IgE recurrent infection syndrome,STAT3
243700,"Hyper-IgE recurrent infection syndrome, autosomal recessive",DOCK8
256450,"Hyperinsulinemic hypoglycemia, familial, 1",ABCC8
601820,"Hyperinsulinemic hypoglycemia, familial, 2",KCNJ11
602485,"Hyperinsulinemic hypoglycemia, familial, 3",GCK
609975,"Hyperinsulinemic hypoglycemia, familial, 4",HADHSC
609968,"Hyperinsulinemic hypoglycemia, familial, 5",INSR
610021,"Hyperinsulinemic hypoglycemia, familial, 7",SLC16A1
606762,Hyperinsulinism-hyperammonemia syndrome,GLUD1
613345,"Hyperkalemic periodic paralysis, type 2",SCN4A
116860,Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations,CCM1
207750,"Hyperlipoproteinemia, type Ib",APOC2
238700,Hyperlysinemia,AASS
250850,"Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency",MAT1A
238970,Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,SLC25A15
144750,"Hyperostosis, endosteal",LRP5
259900,"Hyperoxaluria, primary, type 1",AGXT
260000,"Hyperoxaluria, primary, type II",GRHPR
613616,"Hyperoxaluria, primary, type III",DHDPSL
145000,"Hyperparathyroidism, AD",MEN1
145000,"Hyperparathyroidism, familial primary",HRPT2
239200,"Hyperparathyroidism, neonatal",CASR
145001,Hyperparathyroidism-jaw tumor syndrome,HRPT2
233910,"Hyperpehnylalaninemia, BH4-deficient, B",GCH1
261640,"Hyperphenylalaninemia, BH4-deficient, A",PTS
261630,"Hyperphenylalaninemia, BH4-deficient, C",QDPR
264070,"Hyperphenylalaninemia, BH4-deficient, D",PCBD
612391,"Hyperpigmentation, cutaneous, with hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, and hypogonadism",SLC29A3
145250,"Hyperpigmentation, familial progressive",KITLG
239500,"Hyperprolinemia, type I",PRODH
239510,"Hyperprolinemia, type II",ALDH4A1
605115,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy",NR3C2
145500,"Hypertension, essential",PNMT
145500,"Hypertension, essential",AGTR1
145500,"Hypertension, essential",PTGIS
603373,"Hyperthyroidism, familial gestational",TSHR
609152,"Hyperthyroidism, nonautoimmune",TSHR
259100,"Hypertrophic osteoarthropathy, primary, autosomal recessive",HPGD
162000,"Hyperuricemic nephropathy, familial juvenile 1",UMOD
613092,"Hyperuricemic nephropathy, familial juvenile 2",REN
203400,"Hypoaldosteronism, congenital, due to CMO I deficiency",CYP11B2
610600,"Hypoaldosteronism, congenital, due to CMO II deficiency",CYP11B2
604091,Hypoalphalipoproteinemia,APOA1
146200,"Hypocalcemia, autosomal dominant",CASR
145980,"Hypocalciuric hypercalcemia, type I",CASR
146000,Hypochondroplasia,FGFR3
240800,"Hypoglycemia of infancy, leucine-sensitive",ABCC8
146110,"Hypogonadism, hypogonadotropic",PROK2
227200,Hypogonadotropic hypogonadism due to GNRH deficiency,GNRH1
146110,Hypogonadotropic hypogonadism,CHD7
146110,Hypogonadotropic hypogonadism,FGFR1
146110,Hypogonadotropic hypogonadism,KISS1R
146110,Hypogonadotropic hypogonadism,NELF
146110,Hypogonadotropic hypogonadism,TAC3
146110,Hypogonadotropic hypogonadism,TACR3
170400,Hypokalemic periodic paralysis type 1,CACNA1S
611718,"Hypomagnesemia 4, renal",EGF
602014,Hypomagnesemia with secondary hypocalcemia,TRPM6
248250,"Hypomagnesemia, primary",CLDN16
248190,"Hypomagnesemia, renal, with ocular involvement",CLDN19
154020,"Hypomagnesemia-2, renal",FXYD2
612949,"Hypomyelination, global cerebral",SLC25A12
146200,"Hypoparathyroidism, autosomal dominant",PTH
146200,"Hypoparathyroidism, autosomal recessive",PTH
146200,"Hypoparathyroidism, familial isolated",GCMB
146255,"Hypoparathyroidism, sensorineural deafness, and renal dysplasia",GATA3
241410,Hypoparathyroidism-retardation-dysmorphism syndrome,TBCE
146300,"Hypophosphatasia, adult",ALPL
241510,"Hypophosphatasia, childhood",ALPL
241500,"Hypophosphatasia, infantile",ALPL
307800,"Hypophosphatemia, X-linked",PHEX
241530,Hypophosphatemic rickets with hypercalciuria,SLC34A3
300554,Hypophosphatemic rickets,CLCN5
241520,"Hypophosphatemic rickets, AR",DMP1
193100,"Hypophosphatemic rickets, autosomal dominant",FGF23
613312,"Hypophosphatemic rickets, autosomal recessive, 2",ENPP1
241550,Hypoplastic left heart syndrome,GJA1
241600,"Hypoproteinemia, hypercatabolic",B2M
300633,"Hypospadias 1, X-linked",AR
300758,"Hypospadias 2, X-linked",MAMLD1
275100,"Hypothryoidism, congenital, nongoitrous 4",TSHB
225250,"Hypothyroidism, congenital nongoitrous, 5",NKX2E
218700,"Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia",PAX8
275200,"Hypothyroidism, congenital, nongoitrous",TSHR
613102,Hypotrichosis and recurrent skin vesicles,DSC3
146520,Hypotrichosis simplex of scalp,CDSN
601553,"Hypotrichosis, congenital, with juvenile macular dystrophy",CDH3
146550,"Hypotrichosis, hereditary, Marie Unna type, 1",HR
604379,"Hypotrichosis, localized, autosomal recessive 2",LIPH
611452,"Hypotrichosis, localized, autosomal recessive, 3",P2RY5
607903,"Hypotrichosis, localized, autosomal recessive",DSG4
607823,Hypotrichosis-lymphedema-telangiectasia syndrome,SOX18
612076,"Hypouricemia, renal, 2",SLC2A9
220150,"Hypouricemia, renal",SLC22A12
602540,Hystrix-like ichthyosis with deafness,GJB2
242100,"Ichthyosiform erythroderma, congenital",TGM1
242100,"Ichthyosiform erythroderma, congenital, nonbullous, 1",ALOX12B
242100,"Ichthyosiform erythroderma, congenital, nonbullous, 1",ALOXE3
146800,Ichthyosis bullosa of Siemens,KRT2
308205,"Ichthyosis follicularis, atrichia, and photophobia syndrome",MBTPS2
600962,"Ichthyosis histrix, Curth-Macklin Palmoplantar keratoderma, nonepidermolytic",KRT1
608649,Ichthyosis prematurity syndrome,SLC27A4
146700,Ichthyosis vulgaris,FLG
609165,Ichthyosis with confetti,KRT10
610765,Ichthyosis with hypotrichosis,ST14
612281,"Ichthyosis, congenital, autosomal recessive",ICHYN
607602,"Ichthyosis, cyclic, with epidermolytic hyperkeratosis",KRT1
607602,"Ichthyosis, cyclic, with epidermolytic hyperkeratosis",KRT10
242500,"Ichthyosis, harlequin",ABCA12
601277,"Ichthyosis, lamellar 2",ABCA12
604777,"Ichthyosis, lamellar, 3",CYP4F22
242300,"Ichthyosis, lamellar, autosomal recessive",TGM1
607626,"Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis",CLDN1
308100,"Ichthyosis, x-linked",STS
242600,"Iminoglycinuria, digenic",SLC36A2
242600,"Iminoglycinuria, digenic",SLC6A19
242600,"Iminoglycinuria, digenic",SLC6A20
612782,Immune dysfunction with T-cell inactivation due to calcium entry defect 1,ORAI1
612783,"Immune dysfunction, with T-cell inactivation due to calcium entry defect 2",STIM1
610163,Immunodeficiency due to defect in CD3-zeta,CD247
610798,Immunodeficiency due to defect in MAPBP-interacting protein,MAPBPIP
613179,Immunodeficiency due to purine nucleoside phosphorylase deficiency,PNP
608106,"Immunodeficiency with hyper IgM, type 4",UNG
605258,"Immunodeficiency with hyper-IgM, type 2",AICDA
606843,"Immunodeficiency with hyper-IgM, type 3",TNFRSF5
607594,"Immunodeficiency, common variable, 1",ICOS
240500,"Immunodeficiency, common variable, 2",TNFRSF13B
613493,"Immunodeficiency, common variable, 3",CD19
613494,"Immunodeficiency, common variable, 4",TNFRSF13C
613495,"Immunodeficiency, common variable, 5",MS4A1
613496,"Immunodeficiency, common variable, 6",CD81
612692,"Immunodeficiency, hypogammaglobulinemia, and reduced B cells",CD79B
300584,"Immunodeficiency, isolated",IKBKG
308230,"Immunodeficiency, X-linked, with hyper-IgM",TNFSF5
242860,Immunodeficiency–centromeric instability–facial anomalies syndrome,DNMT3B
304790,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked",FOXP3
609529,Immunoglobulin A deficiency 2,TNFRSF13B
167320,Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia,VCP
600737,"Inclusion body myopathy, autosomal recessive",GNE
605637,Inclusion body myopathy-3,MYH2
308300,"Incontinentia pigmenti, type II",IKBKG
256600,Infantile neuroaxonal dystrophy 1,PLA2G6
612567,Inflammatory bowel disease 25,CRFB4
243000,"Insensitivity to pain, channelopathy-associated",SCN9A
256800,"Insensitivity to pain, congenital, with anhidrosis",NTRK1
600072,"Insomnia, fatal familial",PRNP
604367,"Insulin resistance, severe, digenic",PPARG
604367,"Insulin resistance, severe, digenic",PPP1R3A
270450,"Insulin-like growth factor I, resistance to",IGF1R
612852,Interleukin 1 receptor antagonist deficiency,IL1RN
606367,"Interleukin-2 receptor, alpha chain, deficiency of",IL2RA
300048,"Intestinal pseudoobstruction, neuronal",FLNA
261000,Intrinsic factor deficiency,GIF
610799,"Invasive pneumococcal disease, recurrent isolated, 1",IRAK4
607676,IRAK4 deficiency,IRAK4
601631,"Iridogoniodysgenesis, type 1",FOXC1
137600,"Iridogoniodysgenesis, type 2",PITX2
601631,Iris hypoplasia and glaucoma,FOXC1
206200,Iron-refractory iron deficiency anemia,TMPRSS6
611283,Isobutyryl-coenzyme A dehydrogenase deficiency,ACAD8
243500,Isovaleric acidemia,IVD
147750,IVIC syndrome,SALL4
123150,Jackson–Weiss syndrome,FGFR1
123150,Jackson–Weiss syndrome,FGFR2
217080,Jalili syndrome,CNNM4
311150,Jensen syndrome,TIMM8A
612347,Jervell and Lange-Nielsen syndrome 2,KCNE1
220400,Jervell and Lange-Nielsen syndrome,KCNQ1
243800,Johanson–Blizzard syndrome,UBR1
213300,Joubert syndrome 1,INPP5E
300804,Joubert syndrome 10,OFD1
608091,Joubert syndrome 2,TMEM216
609583,Joubert syndrome 4,NPHP1
610188,Joubert syndrome 5,CEP290
610688,Joubert syndrome 6,TMEM67
611560,Joubert syndrome 7,RPGRIP1L
612291,Joubert syndrome 8,ARL13B
612285,Joubert syndrome 9,CC2D2A
608629,Joubert syndrome-3,AHI1
174900,"Juvenile polyposis syndrome, infantile form",BMPR1A
175050,Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,MADH4
147950,Kallmann syndrome 2,FGFR1
244200,Kallmann syndrome 3,PROKR2
610628,Kallmann syndrome 4,PROK2
612370,Kallmann syndrome 5,CHD7
612702,Kallmann syndrome 6,FGF8
609242,Kanzaki disease,NAGA
610217,Karak syndrome,PLA2G6
244460,Kenny–Caffey syndrome-1,TBCE
148190,Keratitis,PAX6
148210,Keratitis–ichthyosis–deafness syndrome,GJB2
148300,Keratoconus,VSX1
148350,"Keratoderma, palmoplantar, with deafness",GJB2
308800,Keratosis follicularis spinulosa decalvans,SAT1
601952,Keratosis linearis with ichthyosis congenita and sclerosing keratoderma,POMP
148700,Keratosis palmoplantaris striata I,DSG1
612908,Keratosis palmoplantaris striata II,DSP
607654,Keratosis palmoplantaris striata III,KRT1
182000,"Keratosis, seborrheic, somatic",PIK3CA
245150,Keutel syndrome,MGP
173650,Kindler syndrome,KIND1
610253,Kleefstra syndrome,EHMT1
118100,"Klippel–Feil syndrome, autosomal dominant",GDF6
156550,Kniest dysplasia,COL2A1
267750,"Knobloch syndrome, type 1",COL18A1
262650,Kowarski syndrome,GH1
245200,Krabbe disease,GALC
611722,"Krabbe disease, atypical",PSAP
236792,L-2-hydroxyglutaric aciduria,L2HGDH
223000,"Lactase deficiency, congenital",LCT
223100,Lactase persistence/nonpersistence,MCM6
245400,"Lactic acidosis, fatal infantile",SUCLG1
245349,Lacticacidemia due to PDX1 deficiency,PDX1
149730,LADD syndrome,FGF10
149730,LADD syndrome,FGFR3
160500,Laing distal myopathy,MYH7
249700,Langer mesomelic dysplasia,SHOX
249700,Langer mesomelic dysplasia,SHOXY
262500,Laron dwarfism,GHR
150250,Larsen syndrome,FLNB
245660,Laryngoonychocutaneous syndrome,LAMA3
607330,Lathosterolosis,SC5DL
609016,LCHAD deficiency,HADHA
204000,Leber congenital amaurosis 1,GUCY2D
611755,Leber congenital amaurosis 10,CEP290
610612,Leber congenital amaurosis 12,RD3
612712,Leber congenital amaurosis 13,RDH12
613341,Leber congenital amaurosis 14,LRAT
204100,Leber congenital amaurosis 2,RPE65
604232,Leber congenital amaurosis 3,SPATA7
604393,Leber congenital amaurosis 4,AIPL1
604537,Leber congenital amaurosis 5,LCA5
604169,"Left ventricular noncompaction 1, with or without congenital heart defects",DTNA
601493,"Left ventricular noncompaction 3, with or without dilated cardiomyopathy",LDB3
613424,Left ventricular noncompaction 4,ACTC1
613426,Left ventricular noncompaction 5,MYH7
601494,Left ventricular noncompaction 6,TNNT2
300183,"Left ventricular noncompaction, X-linked",TAZ
611431,Legius syndrome,SPRED1
256000,Leigh syndrome due to cytochrome c oxidase deficiency,COX15
256000,Leigh syndrome due to mitochondrial complex I deficiency,C8orf38
256000,Leigh syndrome due to mitochondrial complex I deficiency,NDUFA2
256000,Leigh syndrome,BCS1L
256000,Leigh syndrome,DLD
256000,Leigh syndrome,NDUFS3
256000,Leigh syndrome,NDUFS4
256000,Leigh syndrome,NDUFS7
256000,Leigh syndrome,NDUFS8
256000,Leigh syndrome,NDUFV1
256000,Leigh syndrome,SDHA
256000,"Leigh syndrome, due to COX deficiency",SURF1
220111,"Leigh syndrome, French-Canadian type",LRPPRC
308930,"Leigh syndrome, X-linked",PDHA1
605839,Leiomyomatosis and renal cell cancer,FH
308940,"Leiomyomatosis, diffuse, with Alport syndrome",COL4A6
611554,LEOPARD syndrome 2,RAF1
151100,Leopard syndrome,PTPN11
246200,Leprechaunism,INSR
127300,Léri–Weill dyschondrosteosis,SHOX
127300,Leri-Weill dyschondrosteosis,SHOXY
300322,Lesch–Nyhan syndrome,HPRT1
607598,Lethal congenital contractural syndrome 2,ERBB3
611369,Lethal congenital contractural syndrome 3,PIP5K1C
253310,Lethal congenital contracture syndrome 1,GLE1
613065,"Leukemia, acute lymphocytic",BCR
601626,"Leukemia, acute myelogenous",AMLCR2
601626,"Leukemia, acute myelogenous",GMPS
601626,"Leukemia, acute myelogenous",JAK2
601626,"Leukemia, acute myeloid",MLF1
601626,"Leukemia, acute myeloid",NSD1
601626,"Leukemia, acute myeloid",SH3GL1
601626,"Leukemia, acute myeloid",AF10
601626,"Leukemia, acute myeloid",ARHGEF12
601626,"Leukemia, acute myeloid",CEBPA
601626,"Leukemia, acute myeloid",FLT3
601626,"Leukemia, acute myeloid",KIT
601626,"Leukemia, acute myeloid",LPP
601626,"Leukemia, acute myeloid",NPM1
601626,"Leukemia, acute myeloid",NUP214
601626,"Leukemia, acute myeloid",PICALM
601626,"Leukemia, acute myeloid",RUNX1
601626,"Leukemia, acute myeloid",WHSC1L1
601626,"Leukemia, acute myeloid, somatic",ETV6
612376,"Leukemia, acute promyelocytic",RARA
608232,"Leukemia, chronic myeloid",BCR
607785,"Leukemia, juvenile myelomonocytic",ARHGAP26
607785,"Leukemia, juvenile myelomonocytic",NF1
607785,"Leukemia, juvenile myelomonocytic",PTPN11
190685,"Leukemia, megakaryoblastic, of Down syndrome",GATA1
190685,"Leukemia, megakaryoblastic, with or without Down syndrome",GATA1
116920,Leukocyte adhesion deficiency,ITGB2
612840,"Leukocyte adhesion deficiency, type III",KIND3
169500,"Leukodystrophy, adult-onset, autosomal dominant",LMNB1
612443,"Leukodystrophy, dysmyelinating, and spastic paraparesis with or without dystonia",FA2H
608804,"Leukodystrophy, hypomyelinating, 2",GJC2
612233,"Leukodystrophy, hypomyelinating, 4",HSPD1
610532,"Leukodystrophy, hypomyelinating, 5",FAM126A
611105,Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,DARS2
603896,Leukoencephalopathy with vanishing white matter,EIF2B1
603896,Leukoencephalopathy with vanishing white matter,EIF2B2
603896,Leukoencephalopathy with vanishing white matter,EIF2B3
603896,Leukoencephalopathy with vanishing white matter,EIF2B5
612951,"Leukoencephalopathy, cystic, without megalencephaly",RNASET2
603896,Leukoencephaly with vanishing white matter,EIF2B4
176410,"Leydig cell adenoma, somatic, with precocious puberty",LHCGR
238320,Leydig cell hypoplasia with hypergonadotropic hypogonadism,LHCGR
238320,Leydig cell hypoplasia with pseudohermaphroditism,LHCGR
158350,Lhermitte–Duclos syndrome,PTEN
177200,Liddle syndrome,SCNN1B
177200,Liddle syndrome,SCNN1G
151623,Li–Fraumeni syndrome,CDKN2A
151623,Li–Fraumeni syndrome,TP53
609265,Li–Fraumeni syndrome,CHEK2
151623,Li–Fraumeni-like syndrome,TP53
606593,LIG4 syndrome,LIG4
603543,Limb-mammary syndrome,TP63
246650,"Lipase deficiency, combined",LMF1
608594,"Lipodystrophy, congenital generalized, type 1",AGPAT2
269700,"Lipodystrophy, congenital generalized, type 2",BSCL2
612526,"Lipodystrophy, congenital generalized, type 3",CAV1
613327,"Lipodystrophy, congenital generalized, type 4",PTRF
151660,"Lipodystrophy, familial partial",LMNA
604367,"Lipodystrophy, familial partial, type 3",PPARG
608709,"Lipodystrophy, partial, acquired",LMNB2
201710,Lipoid adrenal hyperplasia,STAR
201710,Lipoid congenital adrenal hyperplasia,CYP11A
247100,Lipoid proteinosis,ECM1
611771,Lipoprotein glomerulopathy,APOE
238600,Lipoprotein lipase deficiency,LPL
611603,Lissencephaly 3,TUBA1A
257320,"Lissencephaly syndrome, Norman-Roberts type",RELN
300215,"Lissencephaly, X-linked 2",ARX
300067,"Lissencephaly, X-linked",DCX
607432,Lissencephaly-1,PAFAH1B1
613070,"Liver failure, acute infantile",TRMU
609192,"Loeys–Dietz syndrome, type 1A",TGFBR1
610168,"Loeys–Dietz syndrome, type 1B",TGFBR2
608967,"Loeys–Dietz syndrome, type 2A",TGFBR1
610380,"Loeys–Dietz syndrome, type 2B",TGFBR2
612955,Long QT syndrome 12,SNT1
613485,Long QT syndrome 13,KCNJ5
192500,Long QT syndrome-1,KCNQ1
611819,Long QT syndrome-10,SCN4B
611820,Long QT syndrome-11,AKAP9
603830,Long QT syndrome-3,SCN5A
600919,Long QT syndrome-4,ANK2
170390,Long QT syndrome-7,KCNJ2
611818,Long QT syndrome-9,CAV3
309000,Lowe syndrome,OCRL
309520,Lujan–Fryns syndrome,MED12
211980,Lung cancer,DLEC1
211980,Lung cancer,RASSF1
211980,Lung cancer,KRAS
211980,Lung cancer,PPP2R1B
211980,Lung cancer,SLC22A1L
211980,"Lung cancer, somatic",MAP3K8
238320,"Luteinizing hormone resistance, female",LHCGR
606690,Lymphangioleiomyomatosis,TSC1
606690,"Lymphangioleiomyomatosis, somatic",TSC2
153100,"Lymphedema, hereditary I",FLT4
613480,"Lymphedema, hereditary, IC",GJC2
153400,Lymphedema–distichiasis syndrome with renal disease and diabetes mellitus,FOXC2
153400,Lymphedema–distichiasis syndrome,FOXC2
605027,"Lymphoma, non-Hodgkin",PRF1
605027,"Lymphoma, non-Hodgkin, somatic",RAD54L
613011,"Lymphoproliferative syndrome, EBV-associated, autosomal, 1",ITK
300635,"Lymphoproliferative syndrome, X-linked, 2",BIRC4
308240,"Lymphoproliferative syndrome, X-linked",SH2D1A
222700,Lysinuric protein intolerance,SLC7A7
200950,Lysosomal acid phosphatase deficiency,ACP2
612394,Lysyl hydroxylase 3 deficiency,PLOD3
109150,Machado–Joseph disease,ATXN3
613075,"Macrocephaly, alopecia, cutis laxa, and scoliosis",RIN2
605309,Macrocephaly/autism syndrome,PTEN
153550,"Macrocytic anemia, refractory, due to 5q deletion, somatic",RPS14
600208,Macrothrombocytopenia and progressive sensorineural deafness,MYH9
300367,Macrothrombocytopenia,GATA1
613112,"Macrothrombocytopenia, autosomal dominant, TUBB1-related",TUBB1
217800,Macular corneal dystrophy,CHST6
611953,"Macular degeneration, age-related, 11",CST3
153800,"Macular degeneration, age-related, 2",ABCA4
608895,"Macular degeneration, age-related, 3",FBLN5
248200,Macular degeneration juvenile,CNGB3
600110,"Macular dystrophy, autosomal dominant, chromosome 6-linked",ELOVL4
169150,"Macular dystrophy, patterned",PRPH2
608051,"Macular dystrophy, retinal, 2",PROM1
608161,"Macular dystrophy, vitelliform",PRPH2
609628,Majeed syndrome,LPIN2
608516,Major depressive disorder 1,MDD1
608516,Major depressive disorder 2,MDD2
243060,"Male infertility with large-headed, multiflagellar, polyploid spermatozoa",STK13
612997,"Male infertility, nonsyndromic, autosomal recessive",CATSPER1
248360,Malonyl-CoA decarboxylase deficiency,MLYCD
608612,Mandibuloacral dysplasia with type B lipodystrophy,ZMPSTE24
248370,Mandibuloacral dysplasia,LMNA
248500,"Mannosidosis, alpha-, types I and II",MAN2B1
248510,"Mannosidosis, beta",MANBA
248600,"Maple syrup urine disease, type Ia",BCKDHA
248600,"Maple syrup urine disease, type Ib",BCKDHB
248600,"Maple syrup urine disease, type II",DBT
248600,"Maple syrup urine disease, type III",DLD
154700,Marfan syndrome,FBN1
248800,Marinesco–Sjögren syndrome,SIL1
253200,"Maroteaux–Lamy syndrome, several forms",ARSB
154780,Marshall syndrome,COL11A1
212720,Martsolf syndrome,RAB3GAP2
303350,MASA syndrome,L1CAM
604308,MASS syndrome,FBN1
248900,Mast syndrome,ACP33
606394,Maturity-onset diabetes of the young 6,NEUROD1
613370,"Maturity-onset diabetes of the young, type 10",INS
613375,"Maturity-onset diabetes of the young, type 11",BLK
612225,"Maturity-onset diabetes of the young, type IX",PAX4
610508,"Maturity-onset diabetes of the young, type VII",KLF11
609812,"Maturity-onset diabetes of the young, type VIII",CEL
155100,May–Hegglin anomaly,MYH9
232600,McArdle disease,PYGM
174800,McCune–Albright syndrome,GNAS
236700,McKusick–Kaufman syndrome,MKKS
608978,Meacham syndrome,WT1
267010,Meckel syndrome 7,NPHP3
611134,Meckel syndrome type 4,CEP290
249000,"Meckel syndrome, type 1",MKS1
607361,"Meckel syndrome, type 3",TMEM67
611561,"Meckel syndrome, type 5",RPGRIP1L
612284,"Meckel syndrome, type 6",CC2D2A
603860,Medullary cystic kidney disease 2,UMOD
155240,Medullary thyroid carcinoma,RET
155240,"Medullary thyroid carcinoma, familial",NTRK1
155255,Medulloblastoma,PTCH2
155255,"Medulloblastoma, desmoplastic",SUFU
122100,Meesmann corneal dystrophy,KRT12
122100,Meesmann corneal dystrophy,KRT3
604004,Megalencephalic leukoencephalopathy with subcortical cysts,MLC1
261100,"Megaloblastic anemia-1, Finnish type",CUBN
261100,"Megaloblastic anemia-1, Norwegian type",AMN
155755,Melanoma and neural system tumor syndrome,CDKN2A
609048,Melanoma,CDK4
155601,"Melanoma, cutaneous malignant, 2",CDKN2A
248300,Meleda disease,SLURP1
309350,Melnick–Needles syndrome,FLNA
155950,Melorheostosis with osteopoikilosis,LEMD3
609814,Membranoproliferative glomerulonephritis with CFH deficiency,HF1
607174,Meningioma,MN1
607174,"Meningioma, NF2-related, somatic",NF2
309400,Menkes disease,ATP7A
300749,Mental retardation and microcephaly with pontine and cerebellar hypoplasia,CASK
123450,Mental retardation in cri-du-chat syndrome,CTNND2
300354,"Mental retardation syndrome, X-linked, Cabezas type",CUL4B
300263,"Mental retardation syndrome, X-linked, Siderius type",PHF8
156200,"Mental retardation, autosomal dominant 1",MBD5
612580,"Mental retardation, autosomal dominant 3",CDH15
612581,"Mental retardation, autosomal dominant 4",KIRREL3
612621,"Mental retardation, autosomal dominant 5",SYNGAP
249500,"Mental retardation, autosomal recessive 1",PRSS12
613192,"Mental retardation, autosomal recessive 13",TRAPPC9
607417,"Mental retardation, autosomal recessive 2A",CRBN
608443,"Mental retardation, autosomal recessive 3",CC2D1A
611093,"Mental retardation, autosomal recessive 7",TUSC3
611092,"Mental retardation, autosomal recessive, 6",GRIK2
136630,"Mental retardation, FRA12A type",DIP2B
612652,"Mental retardation, joint hypermobility and skin laxity, with or without metabolic abnormalities",PYCS
613443,"Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations",MEF2C
610156,"Mental retardation, truncal obesity, retinal dystrophy, and micropenis",INPP5E
309530,"Mental retardation, X-linked 1",IQSEC2
300705,"Mental retardation, X-linked 17/31, microduplication",HSD17B10
300558,"Mental retardation, X-linked 30",PAK3
300419,"Mental retardation, X-linked 36/43/54",ARX
300498,"Mental retardation, X-linked 45",ZNF81
300210,"Mental retardation, X-linked 58",TM4SF2
300630,"Mental retardation, X-linked 59",AP1S2
300659,"Mental retardation, X-linked 93",BRWD3
300699,"Mental retardation, X-linked 94",GRIA3
300716,"Mental retardation, X-linked 95",MAGT1
309541,"Mental retardation, X-linked nonspecific",GDI1
300387,"Mental retardation, X-linked nonspecific, 63",ACSL4
300436,"Mental retardation, X-linked nonspecific, type 46",ARHGEF6
300220,"Mental retardation, X-linked syndromic 10",HSD17B10
300243,"Mental retardation, X-linked syndromic, Christianson type",SLC9A6
300706,"Mental retardation, X-linked syndromic, Turner type",HUWE1
300143,"Mental retardation, X-linked, 21/34",IL1RAPL1
300495,"Mental retardation, X-linked",NLGN4
309548,"Mental retardation, X-linked, FRAXE type",AFF2
300260,"Mental retardation, X-linked, Lubs type",MECP2
309583,"Mental retardation, X-linked, Snyder-Robinson type",SMS
300055,"Mental retardation, X-linked, syndromic 13",MECP2
300676,"Mental retardation, X-linked, syndromic 14",UPF3B
300534,"Mental retardation, X-linked, syndromic, JARID1C-related",KDM5C
300486,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance",OPHN1
300423,"Mental retardation, X-linked, with epilepsy",ATP6AP2
300123,"Mental retardation, X-linked, with isolated growth hormone deficiency",SOX3
300802,"Mental retardation, X-linked, with or without epilepsy",SYP
300799,"Mental retardation, X-linked, ZDHHC9-related",ZDHHC9
300271,"Mental retardation, X-linked-72",RAB39B
309549,"Mental retardation, X-linked-9",FTSJ1
300577,"Mental retardation, X-linked-91",ZDHHC15
300639,"Mental retardation-hypotonic facies syndrome, X-linked, 2",CUL4B
309580,"Mental retardation-hypotonic facies syndrome, X-linked",ATRX
609535,Mephenytoin poor metabolizer,CYP2C
156250,Metachondromatosis,PTPN11
249900,Metachromatic leukodystrophy due to SAP-b deficiency,PSAP
250100,Metachromatic leukodystrophy,ARSA
602111,Metaphyseal anadysplasia 1,MMP13
613073,Metaphyseal anadysplasia 2,MMP9
156400,"Metaphyseal chondrodysplasia, Murk Jansen type",PTHR1
250460,Metaphyseal dysplasia without hypotrichosis,RMRP
156530,Metatropic dysplasia,TRPV4
250800,"Methemoglobinemia, type I",CYB5R3
250800,"Methemoglobinemia, type II",CYB5R3
250790,"Methemoglobinemia, type IV",CYB5A
250850,"Methionine adenosyltransferase deficiency, autosomal recessive",MAT1A
250940,"Methylcobalamin deficiency, cblG type",MTR
277400,"Methylmalonic aciduria and homocystinuria, cblC type",MMACHC
277410,"Methylmalonic aciduria and homocystinuria, cblD type",C2orf25
277380,"Methylmalonic aciduria and homocystinuria, cblF type",LMBRD1
613646,Methylmalonic aciduria due to transcobalamin receptor defect,CD320
277410,"Methylmalonic aciduria, cblD type, variant 2",C2orf25
251100,"Methylmalonic aciduria, vitamin B12-responsive",MMAA
251110,"Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type",MMAB
251120,Methylmalonyl-CoA epimerase deficiency,MCEE
610377,Mevalonic aciduria,MVK
209920,"MHC class II deficiency, complementation group B",RFXANK
610773,Micochondrial phosphate carrier deficiency,SLC25A3
210720,Microcephalic osteodysplastic primordial dwarfism type II,PCNT
602585,Microcephaly and digital abnormalities with normal intelligence,MYCN
607196,"Microcephaly, Amish type",SLC25A19
251200,"Microcephaly, autosomal recessive 1",MCPH1
251200,"Microcephaly, primary autosomal recessive, 2",MCPH2
604804,"Microcephaly, primary autosomal recessive, 3",CDK5RAP2
251200,"Microcephaly, primary autosomal recessive, 4",MCPH4
608716,"Microcephaly, primary autosomal recessive, 5, with or without simplified gyral pattern",ASPM
608393,"Microcephaly, primary autosomal recessive, 6",CEMPJ
612703,"Microcephaly, primary autosomal recessive, 7",STIL
613402,"Microcephaly, seizures, and developmental delaty",PNKP
193220,"Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma",BEST1
610093,"Microphthalmia, isolated 2",CHX10
611038,"Microphthalmia, isolated 3",RAX
613094,"Microphthalmia, isolated 4",GDF6
611040,"Microphthalmia, isolated 5",MFRP
212550,"Microphthalmia, isolated, with cataract 2",SIX6
610426,"Microphthalmia, isolated, with cataract 4",CRYBA4
610092,"Microphthalmia, isolated, with coloboma 3",CHX10
611638,"Microphthalmia, isolated, with coloboma 5",SHH
300166,"Microphthalmia, syndromic 2",BCOR
206900,"Microphthalmia, syndromic 3",SOX2
610125,"Microphthalmia, syndromic 5",OTX2
607932,"Microphthalmia, syndromic 6",BMP4
309801,"Microphthalmia, syndromic 7",HCCS
601186,"Microphthalmia, syndromic 9",STRA6
612290,"Microtia, hearing impairment, and cleft palate",HOXA2
251850,Microvillus inclusion disease,MYO5B
602481,"Migraine, familial basilar",ATP1A2
602481,"Migraine, familial hemiplegic, 2",ATP1A2
609634,"Migraine, familial hemiplegic, 3",SCN1A
157300,"Migraine, resistance to",EDNRA
264750,Miller syndrome,DHODH
255320,Minicore myopathy with external ophthalmoplegia,RYR1
157600,"Mirror movements, congenital",DCC
135750,Mirror-image polydactyly,MIPOL1
276300,Mismatch repair cancer syndrome,MLH1
276300,Mismatch repair cancer syndrome,MSH2
276300,Mismatch repair cancer syndrome,MSH6
276300,Mismatch repair cancer syndrome,PMS2
252010,Mitochondrial complex 1 deficiency,C20orf7
252010,Mitochondrial complex I deficiency,NDUFA1
252010,Mitochondrial complex I deficiency,NDUFA11
252010,Mitochondrial complex I deficiency,NDUFAF2
252010,Mitochondrial complex I deficiency,NDUFAF3
252010,Mitochondrial complex I deficiency,NDUFAF4
252010,Mitochondrial complex I deficiency,NDUFS1
252010,Mitochondrial complex I deficiency,NDUFS2
252010,Mitochondrial complex I deficiency,NDUFS4
252010,Mitochondrial complex I deficiency,NDUFV1
252010,Mitochondrial complex I deficiency,NDUFV2
252011,Mitochondrial complex II deficiency,SDHAF1
124000,Mitochondrial complex III deficiency,BCS1L
124000,Mitochondrial complex III deficiency,UQCRB
124000,Mitochondrial complex III deficiency,UQCRQ
220110,Mitochondrial complex IV deficiency,FASTKD2
612073,"Mitochondrial DNA depletion syndrome, encephalomyopathic form, with methylmalonic aciduria",SUCLA2
612075,"Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy",RRM2B
251880,"Mitochondrial DNA depletion syndrome, hepatocerebral form",C10orf2
251880,"Mitochondrial DNA depletion syndrome, hepatocerebral form",MPV17
609560,"Mitochondrial DNA depletion syndrome, myopathic form",TK2
251880,"Mitochondrial DNA-depletion syndrome, hepatocerebral form",DGUOK
600462,Mitochondrial myopathy and sideroblastic anemia,PUS1
603041,Mitochondrial neurogastrointestinal encephalomyopathy syndrome,TYMP
252011,Mitochondrial respiratory chain complex II deficiency,SDHA
613319,Miyoshi muscular dystrophy 3,ANO5
254130,Miyoshi myopathy,DYSF
603041,MNGIE without leukoencephalopathy,POLG
125850,"MODY, type I",HNF4A
125851,"MODY, type II",GCK
600496,"MODY, type III",HNF1A
606392,"MODY, type IV",IPF1
304700,Mohr–Tranebjærg syndrome,TIMM8A
252150,"Molybdenum cofactor deficiency, type A",MOCS1
252150,"Molybdenum cofactor deficiency, type B",MOCS2
252150,"Molybdenum cofactor deficiency, type C",GPHN
158000,Monilethrix,KRT81
158000,Monilethrix,KRT83
158000,Monilethrix,KRT86
613353,"Mononeuropathy of the median nerve, mild",SH3TC2
120430,Morning glory disc anomaly,PAX6
253010,Morquio syndrome B,GLB1
257300,Mosaic variegated aneuploidy syndrome,BUB1B
235730,Mowat–Wilson syndrome,ZEB2
191900,Muckle–Wells syndrome,NLRP3
252500,Mucolipidosis II alpha/beta,GNPTAB
252600,Mucolipidosis III alpha/beta,GNPTAB
252605,Mucolipidosis III gamma,GNPTAG
252650,Mucolipidosis IV,MCOLN1
607014,Mucopolysaccharidosis Ih,IDUA
607015,Mucopolysaccharidosis Ih/s,IDUA
607016,Mucopolysaccharidosis Is,IDUA
253000,Mucopolysaccharidosis IVA,GALNS
252940,Mucopolysaccharidosis type IIID,GNS
601492,Mucopolysaccharidosis type IX,HYAL1
253220,Mucopolysaccharidosis VII,GUSB
602849,Muenke syndrome,FGFR3
158320,Muir–Torre syndrome,MLH1
158320,Muir–Torre syndrome,MSH2
253250,Mulibrey nanism,TRIM37
158330,Mullerian aplasia and hyperandrogenism,WNT4
150800,Multiple cutaneous and uterine leiomyomata,FH
171400,Multiple endocrine neoplasia IIA,RET
162300,Multiple endocrine neoplasia IIB,RET
610755,"Multiple endocrine neoplasia, type IV",CDKN1B
253290,"Multiple pterygium syndrome, lethal type",CHRNA1
253290,"Multiple pterygium syndrome, lethal type",CHRND
253290,"Multiple pterygium syndrome, lethal type",CHRNG
272200,Multiple sulfatase deficiency,SUMF1
612961,Multiple synostoses syndrome 3,FGF9
300559,Muscle glycogenosis,PHKA1
226670,Muscular dystrophy with epidermolysis bullosa simplex,PLEC1
607855,"Muscular dystrophy, congenital merosin-deficient",LAMA2
613204,"Muscular dystrophy, congenital, due to ITGA7 deficiency",ITGA7
607855,"Muscular dystrophy, congenital, due to partial LAMA2 deficiency",LAMA2
159000,"Muscular dystrophy, limb-girdle, type 1A",TTID
159001,"Muscular dystrophy, limb-girdle, type 1B",LMNA
253600,"Muscular dystrophy, limb-girdle, type 2A",CAPN3
253601,"Muscular dystrophy, limb-girdle, type 2B",DYSF
253700,"Muscular dystrophy, limb-girdle, type 2C",SGCG
608099,"Muscular dystrophy, limb-girdle, type 2D",SGCA
604286,"Muscular dystrophy, limb-girdle, type 2E",SGCB
601287,"Muscular dystrophy, limb-girdle, type 2F",SGCD
601954,"Muscular dystrophy, limb-girdle, type 2G",TCAP
254110,"Muscular dystrophy, limb-girdle, type 2H",TRIM32
608807,"Muscular dystrophy, limb-girdle, type 2J",TTN
611307,"Muscular dystrophy, limb-girdle, type 2L",ANO5
607801,"Muscular dystrophy, limb-girdle, type IC",CAV3
602771,"Muscular dystrophy, rigid spine, 1",SEPN1
254300,"Myasthenia, limb-girdle, familial",AGRN
254300,"Myasthenia, limb-girdle, familial",DOK7
608931,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency",CHRNB1
608931,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency",CHRNE
608931,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency",MUSK
608931,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency",RAPSN
254210,"Myasthenic syndrome, congenital, associated with episodic apnea",CHAT
608931,"Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency",RAPSN
608930,"Myasthenic syndrome, fast-channel congenital",CHRNA1
608930,"Myasthenic syndrome, fast-channel congenital",CHRND
608930,"Myasthenic syndrome, fast-channel congenital",CHRNE
601462,"Myasthenic syndrome, slow-channel congenital",CHRNA1
601462,"Myasthenic syndrome, slow-channel congenital",CHRNB1
601462,"Myasthenic syndrome, slow-channel congenital",CHRND
601462,"Myasthenic syndrome, slow-channel congenital",CHRNE
209950,"Mycobacterial infection, atypical, familial disseminated",IFNGR1
209950,"Mycobacterial infection, atypical, familial disseminated",STAT1
254450,"Myelofibrosis, idiopathic",JAK2
254600,Myeloperoxidase deficiency,MPO
131440,Myeloproliferative disorder with eosinophilia,PDGFRB
607208,"Myoclonic epilepsy, severe, of infancy",GABRG2
268200,"Myoglobinuria, acute recurrent, autosomal recessive",LPIN1
606437,Myokymia with neonatal epilepsy,KCNQ2
255110,Myopathy due to CPT II deficiency,CPT2
255125,"Myopathy with lactic acidosis, hereditary",ISCU
161800,"Myopathy, actin, congenital, with excess of thin myofilaments",ACTA1
608810,"Myopathy, cardioskeletal, desmin-related, with cataract",CRYAB
160150,"Myopathy, centronuclear",DNM2
160150,"Myopathy, centronuclear",MYF6
255200,"Myopathy, centronuclear, autosomal recessive",BIN1
612540,"Myopathy, congenital, Compton-North",CNTN1
255310,"Myopathy, congenital, with fiber-type disproportion 1",ACTA1
601419,"Myopathy, desmin-related, cardioskeletal",DES
606070,"Myopathy, distal 2",MATR3
606768,"Myopathy, distal, with anterior tibial onset",DYSF
611705,"Myopathy, early-onset, with fatal cardiomyopathy",TTN
613076,"Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay",GFER
612954,"Myopathy, myofibrillar, BAG3-related",BAG3
609524,"Myopathy, myofibrillar, filamin C-related",FLNC
609452,"Myopathy, myofibrillar, ZASP-related",LDB3
608358,"Myopathy, myosin storage",MYH7
161800,"Myopathy, nemaline, 3",ACTA1
603689,"Myopathy, proximal, with early respiratory muscle involvement",TTN
300718,"Myopathy, reducing body, X-linked, childhood-onset",FHL1
300717,"Myopathy, reducing body, X-linked, severe early-onset",FHL1
182920,"Myopathy, spheroid body",TTID
300696,"Myopathy, X-linked, with postural muscle atrophy",FHL1
255600,"Myosclerosis, congenital",COL6A2
609200,Myotilinopathy,TTID
608390,"Myotonia congenita, atypical, acetazolamide-responsive",SCN4A
160800,"Myotonia congenita, dominant",CLCN1
255700,"Myotonia congenita, recessive",CLCN1
160900,Myotonic dystrophy,DMPK
602668,"Myotonic dystrophy, type 2",ZNF9
310400,"Myotubular myopathy, X-linked",MTM1
613488,Myxoid liposarcoma,DDIT3
255960,"Myxoma, intracardiac",PRKAR1A
310465,N syndrome,POLA
237310,N-Acetylglutamate synthase deficiency,NAGS
161000,Naegeli–Franceschetti–Jadassohn syndrome,KRT14
161200,Nail–patella syndrome,LMX1B
302350,Nance–Horan syndrome,NHS
161400,Narcolepsy 1,HCRT
607107,Nasopharyngeal carcinoma,TP53
221770,Nasu–Hakola disease,TREM2
221770,Nasu–Hakola disease,TYROBP
601214,Naxos disease,JUP
609284,"Nemaline myopathy 1, autosomal dominant",TPM3
256030,"Nemaline myopathy 2, autosomal recessive",NEB
610687,Nemaline myopathy 7,CFL2
609285,Nemaline myopathy,TPM2
605355,"Nemaline myopathy, Amish type",TNNT1
300539,Nephrogenic syndrome of inappropriate antidiuresis,AVPR2
310468,"Nephrolithiasis, type I",CLCN5
612286,"Nephrolithiasis/osteoporosis, hypophosphatemic, 1",SLC34A1
612287,"Nephrolithiasis/osteoporosis, hypophosphatemic, 2",SLC9A3R1
256100,"Nephronophthisis 1, juvenile",NPHP1
602088,"Nephronophthisis 2, infantile",INVS
604387,Nephronophthisis 3,NPHP3
606966,Nephronophthisis 4,NPHP4
611498,Nephronophthisis 7,GLIS2
609057,Nephropathy with pretibial epidermolysis bullosa and deafness,CD151
609049,"Nephrosis, congenital, with or without ocular abnormalities",LAMB2
256300,"Nephrotic syndrome, type 1",NPHS1
600995,"Nephrotic syndrome, type 2",PDCN
610725,"Nephrotic syndrome, type 3",PLCE1
256370,"Nephrotic syndrome, type 4",WT1
256500,Netherton syndrome,SPINK5
182940,Neural tube defect,VANGL1
256700,Neuroblastoma,NME1
613068,Neurodegeneration due to cerebral folate transport deficiency,FOLR1
234200,Neurodegeneration with brain iron accumulation 1,PANK2
610217,Neurodegeneration with brain iron accumulation 2B,PLA2G6
606159,Neurodegeneration with brain iron accumulation 3,FTL
612219,Neuroepithelioma,EWSR1
162210,"Neurofibromatosis, familial spinal",NF1
162200,Neurofibromatosis type 1,NF1
101000,Neurofibromatosis type 2,NF2
601321,Neurofibromatosis-Noonan syndrome,NF1
117000,"Neuromuscular disease, congenital, with uniform type 1 fiber",RYR1
613376,"Neuronopathy, distal hereditary motor, type IIC",HSPB3
604320,"Neuronopathy, distal hereditary motor, type VI",IGHMBP2
605253,"Neuropathy, congenital hypomyelinating, 1",EGR2
605253,"Neuropathy, congenital hypomyelinating",MPZ
158590,"Neuropathy, distal hereditary motor, type IIA",HSPB8
608634,"Neuropathy, distal hereditary motor, type IIB",HSPB1
600794,"Neuropathy, distal hereditary motor, type V",BSCL2
600794,"Neuropathy, distal hereditary motor, type V",GARS
607641,"Neuropathy, distal hereditary motor, type VIIB",DCTN1
162400,"Neuropathy, hereditary sensory and autonomic, type 1",SPTLC1
201300,"Neuropathy, hereditary sensory and autonomic, type II",WNK1
613115,"Neuropathy, hereditary sensory and autonomic, type IIB",FAM134B
608654,"Neuropathy, hereditary sensory and autonomic, type V",NGFB
256840,"Neuropathy, hereditary sensory, with spastic paraplegia",CCT5
613640,"Neuropathy, hereditary sensory/autonomic, type IC",SPTLC2
162500,"Neuropathy, recurrent, with pressure palsies",PMP22
610717,Neutral lipid storage disease with myopathy,PNPLA2
607847,"Neutropenia, nonimmune chronic idiopathic, of adults",GFI1
202700,"Neutropenia, severe congenital, autosomal dominant 1",ELANE
613107,"Neutropenia, severe congenital, autosomal dominant 2",GFI1
610738,"Neutropenia, severe congenital, autosomal recessive 3",HAX1
612541,"Neutropenia, severe congenital, autosomal recessive 4",G6PC3
300299,"Neutropenia, severe congenital, X-linked",WAS
608203,Neutrophil immunodeficiency syndrome,RAC2
162830,"Neutrophilia, hereditary",CSF3R
601451,Nevo syndrome,PLOD
162900,"Nevus, epidermal",PIK3CA
600648,"Nevus, epidermal, epidermolytic hyperkeratotic type",KRT10
162900,"Nevus, keratinocytic, nonepidermolytic",FGFR3
607476,Newfoundland rod-cone dystrophy,RLBP1
257200,"Niemann–Pick disease, type A",SMPD1
607616,"Niemann–Pick disease, type B",SMPD1
257220,"Niemann–Pick disease, type C1",NPC1
607625,"Niemann–Pick disease, type C2",NPC2
257220,Niemann–Pick disease type D,NPC1
163500,"Night blindness, congenital stationary, autosomal dominant 2",PDE6B
610444,"Night blindness, congenital stationary, autosomal dominant 3",GNAT1
310500,"Night blindness, congenital stationary, type 1",CSNB1
257270,"Night blindness, congenital stationary, type 1B",GRM6
610427,"Night blindness, congenital stationary, type 2B",CABP4
613216,"Night blindness, congenital stationary, type IC",TRPM1
300071,"Night blindness, congenital stationary, X-linked, type 2A",CACNA1F
610445,"Night blindness, congenital stationary, autosomal dominant 1",RHO
251260,Nijmegen breakage syndrome,NBS1
613078,Nijmegen breakage syndrome-like disorder,RAD50
605820,Nonaka myopathy,GNE
605027,"Non-Hodgkin lymphoma, somatic",CASP10
211980,"Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in",EGFR
211980,"Nonsmall cell lung cancer, somatic",IRF1
211980,"Nonsmall cell lung cancer, somatic",PIK3CA
163950,Noonan syndrome 1,PTPN11
609942,Noonan syndrome 3,KRAS
610733,Noonan syndrome 4,SOS1
611553,Noonan syndrome 5,RAF1
613224,Noonan syndrome 6,NRAS
607721,Noonan-like syndrome with loose anagen hair,SHOC2
310600,Norrie disease,NDP
245900,Norum disease,LCAT
310700,"Nystagmus 1, congenital, X-linked",FRMD7
300814,"Nystagmus 6, congenital, X-linked",GPR143
600955,Obesity with impaired prohormone processing,PCSK1
609734,"Obesity, adrenal insufficiency, and red hair due to POMC deficiency",POMC
601665,"Obesity, autosomal dominant",MC4R
601665,"Obesity, mild, early-onset",NR0B2
601665,"Obesity, severe",PPARG
601665,"Obesity, severe",SIM1
304150,Occipital horn syndrome,ATP7A
300500,"Ocular albinism, type I, Nettleship-Falls type",GPR143
612109,Oculoauricular syndrome,HMX1
606574,"Oculocutaneous albinism, type IV",SLC45A2
164200,Oculodentodigital dysplasia,GJA1
257850,"Oculodentodigital dysplasia, autosomal recessive",GJA1
164300,Oculopharyngeal muscular dystrophy,PABPN1
146300,Odontohypophosphatasia,ALPL
257980,Odontoonychodermal dysplasia,WNT10A
300855,Ogden syndrome,NAA10
258100,Oguchi disease-1,SAG
613411,Oguchi disease-2,GRK1
166210,OI type II,COL1A1
259420,OI type III,COL1A1
166220,OI type IV,COL1A1
608615,Oligodontia-colorectal cancer syndrome,AXIN2
603554,Omenn syndrome,DCLRE1C
603554,Omenn syndrome,RAG1
603554,Omenn syndrome,RAG2
258315,Omodysplasia 1,GPC6
300000,"Opitz G syndrome, type I",MID1
305450,Opitz–Kaveggia syndrome,MED12
609535,Opremazole poor metabolizer,CYP2C
165500,Optic atrophy 1,OPA1
165300,Optic atrophy and cataract,OPA3
125250,Optic atrophy and deafness,OPA1
612989,Optic atrophy-7,TMEM126A
120330,Optic nerve coloboma with renal disease,PAX2
206900,Optic nerve hypoplasia and abnormalities of the central nervous system,SOX2
165550,Optic nerve hypoplasia,PAX6
311200,Oral-facial-digital syndrome 1,OFD1
311250,Ornithine transcarbamylase deficiency,OTC
600625,Orofacial cleft 11,BMP4
608874,Orofacial cleft 5,MSX1
608864,Orofacial cleft 6,IRF6
225060,Orofacial cleft 7,HVEC
129400,Orofacial cleft 8,TP63
604715,Orthostatic intolerance,SLC6A2
166350,"Osseous heteroplasia, progressive",GNAS
602475,Ossification of posterior longitudinal ligament of spine,ENPP1
604864,Osteoarthritis with mild chondrodysplasia,COL2A1
165800,"Osteochondritis dissecans, short stature, and early-onset osteoarthritis",ACAN
166200,"Osteogenesis imperfecta, type I",COL1A1
166210,"Osteogenesis imperfecta, type II",COL1A2
610854,"Osteogenesis imperfecta, type IIB",CRTAP
259420,"Osteogenesis imperfecta, type III",COL1A2
166220,"Osteogenesis imperfecta, type IV",COL1A2
259440,"Osteogenesis imperfecta, type IX",PPIB
610698,"Osteogenesis imperfecta, type VI",FKBP10
610682,"Osteogenesis imperfecta, type VII",CRTAP
610915,"Osteogenesis imperfecta, type VIII",LEPRE1
166250,Osteoglophonic dysplasia,FGFR1
174810,"Osteolysis, familial expansile",TNFRSF11A
300373,Osteopathia striata with cranial sclerosis,FAM123B
607634,"Osteopetrosis, AD type I",LRP5
166600,"Osteopetrosis, autosomal dominant 2",CLCN7
259710,"Osteopetrosis, autosomal recessive 2",TNFSF11
259730,"Osteopetrosis, autosomal recessive 3, with renal tubular acidosis",CA2
611490,"Osteopetrosis, autosomal recessive 4",CLCN7
259720,"Osteopetrosis, autosomal recessive 5",OSTM1
611497,"Osteopetrosis, autosomal recessive 6",PLEKHM1
612301,"Osteopetrosis, autosomal recessive 7",TNFRSF11A
259700,"Osteopetrosis, recessive 1",TCIRG1
166700,Osteopoikilosis,LEMD3
166710,"Osteoporosis, involutional",VDR
259770,Osteoporosis-pseudoglioma syndrome,LRP5
259500,Osteosarcoma,LOH18CR1
259500,Osteosarcoma,RB1
259500,Osteosarcoma,TP53
259500,"Osteosarcoma, somatic",CHEK2
144750,Osteosclerosis,LRP5
166780,Otofaciocervical syndrome,EYA1
311300,"Otopalatodigital syndrome, type I",FLNA
304120,"Otopalatodigital syndrome, type II",FLNA
215150,Otospondylomegaepiphyseal dysplasia,COL11A2
167000,Ovarian cancer,CTNNB1
604370,"Ovarian cancer, somatic",AKT1
604370,"Ovarian cancer, somatic",PIK3CA
233300,Ovarian dysgenesis 1,FSHR
300510,Ovarian dysgenesis 2,BMP15
608115,Ovarian hyperstimulation syndrome,FSHR
276400,Ovarian response to FSH stimulation,FSHR
603896,Ovarioleukodystrophy,EIF2B2
603896,Ovarioleukodystrophy,EIF2B4
603896,Ovarioleukodystrophy,EIF2B5
167210,Pachyonychia congenita Jackson Lawler type,KRT17
167210,Pachyonychia congenita Jackson Lawler type,KRT6B
167200,"Pachyonychia congenita, Jadassohn-Lewandowsky type",KRT16
167200,"Pachyonychia congenita, Jadassohn-Lewandowsky type",KRT6A
602080,Paget disease of bone,PDB4
602080,Paget disease of bone,SQSTM1
602080,Paget disease of bone,TNFRSF11A
239000,"Paget disease, juvenile",TNFRSF11B
146510,Pallister–Hall syndrome,GLI3
610644,Palmoplantar hyperkeratosis and true hermaphroditism,RSPO1
610644,Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal,RSPO1
600962,"Palmoplantar keratoderma, nonepidermolytic",KRT16
613000,"Palmoplantar keratoderma, nonepidermolytic, focal",KRT16
144200,"Palmoplantar verrucous nevus, unilateral",KRT16
260370,Pancreatic agenesis,IPF1
260350,Pancreatic cancer,TP53
613347,Pancreatic cancer,BRCA2
606719,Pancreatic cancer/melanoma syndrome,CDKN2A
260350,"Pancreatic carcinoma, somatic",KRAS
167800,"Pancreatitis, hereditary",PRSS1
167800,"Pancreatitis, hereditary",SPINK1
312000,"Panhypopituitarism, X-linked",SOX3
245000,Papillon–Lefèvre syndrome,CTSC
606864,Paraganglioma and gastric stromal sarcoma,SDHB
606864,Paraganglioma and gastric stromal sarcoma,SDHC
606864,Paraganglioma and gastric stromal sarcoma,SDHD
115310,"Paraganglioma, familial chromaffin, 4",SDHB
601650,Paragangliomas 2,SDHAF2
168000,"Paragangliomas, familial nonchromaffin, 1, with or without deafness",SDHD
605373,"Paragangliomas, familial nonchromaffin, 3",SDHC
168300,Paramyotonia congenita,SCN4A
145001,Parathyroid adenoma with cystic changes,HRPT2
608266,Parathyroid carcinoma,HRPT2
168500,Parietal foramina 1,MSX2
609597,Parietal foramina 2,ALX4
168550,Parietal foramina with cleidocranial dysplasia,MSX2
608355,Parkes Weber syndrome,RASA1
607688,Parkinson disease 11,GIGYF2
610297,Parkinson disease 13,HTRA2
260300,"Parkinson disease 15, autosomal recessive",FBXO7
605543,Parkinson disease 4,SNCA
605909,"Parkinson disease 6, early onset",PINK1
606324,"Parkinson disease 7, autosomal recessive early-onset",DJ1
606693,Parkinson disease 9,ATP13A2
600116,"Parkinson disease, juvenile, type 2",PRKN
607060,Parkinson disease-8,LRRK2
613135,"Parkinsonism-dystonia, infantile",SLC6A3
167400,Paroxysmal extreme pain disorder,SCN9A
300818,"Paroxysmal nocturnal hemoglobinuria, somatic",PIGA
118800,Paroxysmal nonkinesigenic dyskinesia,MR1
309510,Partington syndrome,ARX
609136,PCWH syndrome,SOX10
609796,"Peeling skin syndrome, acral type",TGM5
169400,Pelger–Huët anomaly,LBR
312080,Pelizaeus–Merzbacher disease,PLP1
274600,Pendred syndrome,SLC26A4
260800,Pentosuria,DCXR
142680,"Periodic fever, familial",TNFRSF1A
170650,"Periodontitis, juvenile",CTSC
608097,Periventricular heterotopia with microcephaly,ARFGEF2
264470,Peroxisomal acyl-CoA oxidase deficiency,ACOX1
168605,Perry syndrome,DCTN1
261550,"Persistent Mullerian duct syndrome, type I",AMH
261550,"Persistent Mullerian duct syndrome, type II",AMHR2
217095,Persistent truncus arteriosus,NKX2-6
604229,Peters anomaly,CYP1B1
604229,Peters anomaly,PAX6
604229,Peters anomaly,PITX2
261540,Peters-plus syndrome,B3GALTL
175200,Peutz–Jeghers syndrome,STK11
101600,Pfeiffer syndrome,FGFR1
101600,Pfeiffer syndrome,FGFR2
261600,Phenylketonuria,PAH
171300,Pheochromocytoma,KIF1B
171300,Pheochromocytoma,RET
171300,Pheochromocytoma,SDHB
171300,Pheochromocytoma,SDHD
171300,Pheochromocytoma,VHL
601815,Phosphoglycerate dehydrogenase deficiency,PHGDH
300653,Phosphoglycerate kinase 1 deficiency,PGK1
300661,Phosphoribosylpyrophosphate synthetase superactivity,PRPS1
261750,"Phosphorylase kinase deficiency of liver and muscle, autosomal recessive",PHKB
610992,Phosphoserine aminotransferase deficiency,PSAT1
172700,Pick disease,MAPT
172700,Pick disease,PSEN1
172800,Piebaldism,SNAI2
609049,Pierson syndrome,LAMB2
610489,"Pigmented adrenocortical disease, primary, 1",PRKAR1A
610475,"Pigmented nodular adrenocortical disease, primary, 2",PDE11A
172870,Pigmented paravenous chorioretinal atrophy,CRB1
132600,Pilomatricoma,CTNNB1
610042,Pitt–Hopkins-like syndrome 1,CNTNAP2
610954,Pitt–Hopkins syndrome,TCF4
219090,"Pituitary adenoma, ACTH-secreting",AIP
102200,"Pituitary adenoma, growth hormone-secreting",AIP
600634,"Pituitary adenoma, prolactin-secreting",AIP
613038,"Pituitary hormone deficiency, combined, 1",POU1F1
262600,"Pituitary hormone deficiency, combined, 2",PROP1
221750,"Pituitary hormone deficiency, combined, 3",LHX3
262700,"Pituitary hormone deficiency, combined, 4",LHX4
182230,"Pituitary hormone deficiency, combined, 5",HESX1
144200,"Plamoplantar keratoderma, epidermolytic",KRT1
613329,"Plasminogen activator inhibitor, type I",PAI1
601399,"Platelet disorder, familial, with associated myeloid malignancy",RUNX1
608404,Platelet glycoprotein IV deficiency,CD36
601200,Pleuropulmonary blastoma,DICER1
173600,"Pneumothorax, primary spontaneous",FLCN
604173,Poikiloderma with neutropenia,C16orf57
263200,Polycystic kidney and hepatic disease,FCYT
613095,Polycystic kidney disease 2,PKD2
173900,"Polycystic kidney disease, adult type I",PKD1
174050,Polycystic liver disease,PRKCSH
174050,Polycystic liver disease,SEC63
184700,Polycystic ovary syndrome,FST
263300,Polycythemia vera,JAK2
263400,"Polycythemia, benign familial",VHL
174200,"Polydactyly, postaxial, types A1 and B",GLI3
174500,"Polydactyly, preaxial type II",LMBR1
174700,"Polydactyly, preaxial, type IV",GLI3
611087,"Polyhydramnios, megalencephaly, and symptomatic epilepsy",STRADA
613180,Polymicrogyria with optic nerve hypoplasia,TUBA8
610031,"Polymicrogyria, asymmetric",TUBB2B
606854,"Polymicrogyria, bilateral frontoparietal",GPR56
610069,"Polyposis syndrome, hereditary mixed, 2",BMPR1A
174900,"Polyposis, juvenile intestinal",BMPR1A
174900,"Polyposis, juvenile intestinal",MADH4
607596,Pontocerebellar hypoplasia type 1,VRK1
277470,Pontocerebellar hypoplasia type 2A,TSEN54
612389,Pontocerebellar hypoplasia type 2B,TSEN2
612390,Pontocerebellar hypoplasia type 2C,TSEN34
225753,Pontocerebellar hypoplasia type 4,TSEN54
611523,"Pontocerebellar hypoplasia, type 6",RARS2
119500,Popliteal pterygium syndrome,IRF6
201750,POR deficiency,POR
175780,Porencephaly,COL4A1
175900,"Porokeratosis, disseminated superficial actinic, 1",SART3
176100,Porphyria cutanea tarda,UROD
176200,Porphyria variegata,PPOX
612740,"Porphyria, acute hepatic",ALAD
176000,"Porphyria, acute intermittent",HMBS
176000,"Porphyria, acute intermittent, nonerythroid variant",HMBS
263700,"Porphyria, congenital erythropoietic",UROS
176100,"Porphyria, hepatoerythropoietic",UROD
176270,Prader–Willi syndrome,NDN
176270,Prader–Willi syndrome,SNRPN
176400,"Precocious puberty, central",KISS1R
176410,"Precocious puberty, male",LHCGR
606858,Premature chromosome condensation with microcephaly and mental retardation,MCPH1
300604,Premature ovarian failure 2B,FLJ22792
608996,Premature ovarian failure 3,FOXL2
300510,Premature ovarian failure 4,BMP15
611548,Premature ovarian failure 5,NOBOX
612310,Premature ovarian failure 6,FIGLA
612964,Premature ovarian failure 7,NR5A1
300511,Premature ovarian failure,DIAPH2
606353,"Primary lateral sclerosis, juvenile",ALS2
606688,Prion disease with protracted course,PRNP
264080,Progesterone resistance,PGR
609283,Progressive external ophthalmoplegia with mitochondrial DNA deletions 3,SLC25A4
609286,Progressive external ophthalmoplegia with mitochondrial DNA deletions 3,C10orf2
610131,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4",POLG2
613077,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5",RRM2B
157640,"Progressive external ophthalmoplegia, autosomal dominant, with or without hypogonadism",POLG
258450,"Progressive external ophthalmoplegia, autosomal recessive",POLG
604559,"Progressive familial heart block, type IB",TRPM4
609535,Proguanil poor metabolizer,CYP2C
170100,Prolidase deficiency,PEPD
225790,Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome,FLVCR2
312060,"Properdin deficiency, X-linked",PFC
606054,Propionicacidemia,PCCA
606054,Propionicacidemia,PCCB
601518,"Prostate cancer 1, 176807",RNASEL
176807,Prostate cancer,BRCA2
176807,"Prostate cancer, hereditary",MSR1
603688,"Prostate cancer, progression and metastasis of",EPHB2
176807,"Prostate cancer, somatic",KLF6
176807,"Prostate cancer, somatic",MAD1L1
308990,"Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis",CLCN5
177000,"Protoporphyria, erythropoietic, autosomal dominant",FECH
177000,"Protoporphyria, erythropoietic, autosomal recessive",FECH
300752,"Protoporphyria, erythropoietic, X-linked dominant",ALAS2
300004,Proud syndrome,ARX
177170,Pseudoachondroplasia,COMP
264300,"Pseudohermaphroditism, male, with gynecomastia",HSD17B3
177720,"Pseudohyperkalemia, familial",PIEZO1
177735,"Pseudohypoaldosteronism type I, autosomal dominant",NR3C2
145260,Pseudohypoaldosteronism type II,WNK4
264350,"Pseudohypoaldosteronism, type I",SCNN1A
264350,"Pseudohypoaldosteronism, type I",SCNN1B
264350,"Pseudohypoaldosteronism, type I",SCNN1G
145260,"Pseudohypoaldosteronism, type IIC",WNK1
103580,Pseudohypoparathyroidism Ia,GNAS
603233,Pseudohypoparathyroidism Ib,GNAS
612462,Pseudohypoparathyroidism Ic,GNAS
603233,"Pseudohypoparathyroidism, type IB",GNASAS
603233,"Pseudohypoparathyroidism, type IB",STX16
264600,Pseudovaginal perineoscrotal hypospadias,SRD5A2
264800,Pseudoxanthoma elasticum,ABCC6
177850,"Pseudoxanthoma elasticum, forme fruste",ABCC6
610842,Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency,GGCX
178300,"Ptosis, congenital",ZFHX4
265100,Pulmonary alveolar microlithiasis,SLC34A2
300770,Pulmonary alveolar proteinosis,CSF2RA
178500,"Pulmonary fibrosis, idiopathic",SFTPA2
178600,"Pulmonary hypertension, familial primary",BMPR2
178600,"Pulmonary hypertension, primary",MADH9
178600,"Pulmonary hypertension, primary, fenfluramine-associated",BMPR2
265450,Pulmonary veno occlusive disease,BMPR2
265800,Pycnodysostosis,CTSK
612260,"Pyogenic bacterial infections, recurrent, due to MYD88 deficiency",MYD88
604416,"Pyogenic sterile arthritis, pyoderma gangrenosum, and acne",PSTPIP1
610090,Pyridoxamine 5'-phosphate oxidase deficiency,PNPO
266140,Pyropoikilocytosis,SPTA1
266150,Pyruvate carboxylase deficiency,PC
312170,Pyruvate dehydrogenase deficiency,PDHA1
245348,Pyruvate dehydrogenase E2 deficiency,DLAT
608782,Pyruvate dehydrogenase phosphatase deficiency,PDP1
266200,Pyruvate kinase deficiency,PKLR
262190,Rabson–Mendenhall syndrome,INSR
605432,Radioulnar synostosis with amegakaryocytic thrombocytopenia,HOXA11
259775,Raine syndrome,FAM20C
266280,RAPADILINO syndrome,RECQL4
129400,Rapp–Hodgkin syndrome,TP63
612042,Recombination rate QTL 1,RNF212
266500,Refsum disease,PEX7
266500,Refsum disease,PHYH
266510,"Refsum disease, infantile form",PEX26
266510,"Refsum disease, infantile form",PXMP3
266510,"Refsum disease, infantile",PEX1
191830,Renal adysplasia,UPK3A
191830,Renal agenesis,RET
144700,"Renal carcinoma, chromophobe, somatic",FLCN
144700,Renal cell carcinoma,DIRC2
144700,Renal cell carcinoma,HNF1A
144700,Renal cell carcinoma,RNF139
144700,"Renal cell carcinoma, clear cell, somatic",OGG1
605074,"Renal cell carcinoma, papillary, 1",PRCC
605074,"Renal cell carcinoma, papillary, 1",TFE3
605074,"Renal cell carcinoma, papillary, familial and sporadic",MET
144700,"Renal cell carcinoma, somatic",VHL
137920,Renal cysts and diabetes syndrome,HNF1B
233100,Renal glucosuria,SLC5A2
267300,Renal tubular acidosis with deafness,ATP6B1
179800,"Renal tubular acidosis, distal, AD",SLC4A1
611590,"Renal tubular acidosis, distal, AR",SLC4A1
602722,"Renal tubular acidosis, distal, autosomal recessive",ATP6V0A4
604278,"Renal tubular acidosis, proximal, with ocular abnormalities",SLC4A4
267430,Renal tubular dysgenesis,ACE
267430,Renal tubular dysgenesis,AGT
267430,Renal tubular dysgenesis,AGTR1
267430,Renal tubular dysgenesis,REN
208540,Renal-hepatic-pancreatic dysplasia,NPHP3
309500,Renpenning syndrome,PQBP1
275210,"Restrictive dermopathy, lethal",ZMPSTE24
267500,Reticular dysgenesis,AK2
610024,Retinal cone dystrophy 3,PDE6H
610356,Retinal cone dystrophy 3B,KCNV2
610478,Retinal cone dystrophy 4,CACNA2D4
605670,"Retinal degeneration, late-onset, autosomal dominant",C1QTNF5
248200,"Retinal dystrophy, early-onset severe",ABCA4
613341,"Retinal dystrophy, early-onset severe",LRAT
610359,Retinitis pigmentosa 33,SNRNP200
613464,Retinitis pigmentosa 51,TTC8
613428,Retinitis pigmentosa 54,C2orf71
613575,Retinitis pigmentosa 55,ARL6
613617,Retinitis pigmentosa 58,ZNF513
613194,"Retinitis pigmentosa, concentric",BEST1
608133,"Retinitis pigmentosa, digenic",PRPH2
613341,"Retinitis pigmentosa, juvenile",LRAT
268000,"Retinitis pigmentosa, juvenile, autosomal recessive",SPATA7
268000,"Retinitis pigmentosa, late-onset dominant",CRX
300455,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness",RPGR
180100,Retinitis pigmentosa-1,RP1
180105,Retinitis pigmentosa-10,IMPDH1
600138,Retinitis pigmentosa-11,PRPF31
600105,"Retinitis pigmentosa-12, autosomal recessive",CRB1
600059,Retinitis pigmentosa-13,PRPF8
600132,Retinitis pigmentosa-14,TULP1
600852,Retinitis pigmentosa-17,CA4
601414,Retinitis pigmentosa-18,HPRP3
601718,Retinitis pigmentosa-19,ABCA4
312600,Retinitis pigmentosa-2,RP2
602772,Retinitis pigmentosa-25,EYS
608380,Retinitis pigmentosa-26,CERKL
300029,Retinitis pigmentosa-3,RPGR
607921,Retinitis pigmentosa-30,FSCN2
609923,Retinitis pigmentosa-31,TOPORS
610282,Retinitis pigmentosa-35,SEMA4A
610599,Retinitis pigmentosa-36,PRCD
611131,Retinitis pigmentosa-37,NR2E3
268000,Retinitis pigmentosa-38,MERTK
268000,Retinitis pigmentosa-39,USH2A
612095,Retinitis pigmentosa-41,PROM1
612943,Retinitis pigmentosa-42,KLHL7
268000,Retinitis pigmentosa-45,CNGB1
613194,Retinitis pigmentosa-50,BEST1
608133,Retinitis pigmentosa-7,PRPH2
180104,Retinitis pigmentosa-9,RP9
136880,Retinitis punctata albescens,PRPH2
136880,Retinitis punctata albescens,RLBP1
133780,Retinopathy of prematurity,FZD4
312750,Rett syndrome,MECP2
613454,"Rett syndrome, congenital variant",FOXG1B
312750,"Rett syndrome, preserved speech variant",MECP2
268130,Revesz syndrome,TINF2
613471,Reynolds syndrome,LBR
609322,Rhabdoid predisposition syndrome 1,SMARCB1
613325,Rhabdoid tumor predisposition syndrome 2,SMARCA4
268220,"Rhabdomyosarcoma 2, alveolar",PAX3
268220,"Rhabdomyosarcoma 2, alveolar",PAX7
268210,Rhabdomyosarcoma,SLC22A1L
268220,"Rhabdomyosarcoma, alveolar",FOXO1A
215100,Rhizomelic chondrodysplasia punctata type 1,PEX7
600121,Rhizomelic chondrodysplasia punctata type 3,AGPS
608611,Ribose-5-phosphate isomerase deficiency,RPIA
600081,Rickets due to defect in vitamin D 25-hydroxylation,CYP2R1
277440,"Rickets, vitamin D-resistant, type IIA",VDR
611943,RIDDLE syndrome,RNF168
602482,Rieger or Axenfeld anomalies,FOXC1
180550,Ring dermoid of cornea,PITX2
606072,Rippling muscle disease,CAV3
606072,Rippling muscle disease-1,RMD1
268300,Roberts syndrome,ESCO2
268310,"Robinow syndrome, autosomal recessive",ROR2
300643,"Rolandic epilepsy, mental retardation, and speech dyspraxia",SRPX2
268400,Rothmund–Thomson syndrome,RECQL4
180800,Roussy–Lévy syndrome,MPZ
180800,Roussy–Lévy syndrome,PMP22
180849,Rubenstein-Taybi syndrome,CREBBP
180849,Rubinstein–Taybi syndrome,EP300
268700,Saccharopinuria,AASS
101400,Saethre–Chotzen syndrome with eyelid anomalies,TWIST1
101400,Saethre–Chotzen syndrome,FGFR2
101400,Saethre–Chotzen syndrome,TWIST1
604369,Salla disease,SLC17A5
268800,"Sandhoff disease, infantile, juvenile, and adult forms",HEXB
252900,"Sanfilippo syndrome, type A",SGSH
252920,"Sanfilippo syndrome, type B",NAGLU
252930,"Sanfilippo syndrome, type C",HGSNAT
609464,"Sarcoidosis, early-onset",NOD2
269000,SC phocomelia syndrome,ESCO2
300695,"Scapuloperoneal myopathy, X-linked dominant",FHL1
181405,Scapuloperoneal spinal muscular atrophy,TRPV4
181430,"Scapuloperoneal syndrome, myopathic type",MYH7
181400,"Scapuloperoneal syndrome, neurogenic, Kaeser type",DES
242900,Schimke immunoosseous dysplasia,SMARCAL1
609241,"Schindler disease, type I",NAGA
609241,"Schindler disease, type III",NAGA
269150,Schinzel–Giedion midface retraction syndrome,SETBP1
269160,Schizencephaly,EMX2
181500,Schizophrenia,DISC2
269250,Schneckenbecken dysplasia,SLC35D1
224750,Schöpf–Schulz–Passarge syndrome,WNT10A
162091,Schwannomatosis,NF2
255800,"Schwartz–Jampel syndrome, type 1",HSPG2
269500,Sclerosteosis,SOST
269600,Sea-blue histiocyte disease,APOE
605249,Sebastian syndrome,MYH9
610227,Seborrhea-like dermatitis with psoriasiform elements,ZNF750
210600,Seckel syndrome 1,ATR
183900,SED congenita,COL2A1
605407,"Segawa syndrome, recessive",TH
242300,Self-healing collodion baby,TGM1
612847,"SEMD, Pakistani type",PAPSS2
606996,Senior–Loken syndrome 4,NPHP4
609254,Senior–Loken syndrome 5,IQCB1
610189,Senior–Loken syndrome 6,CEP290
266900,Senior–Loken syndrome-1,NPHP1
602522,Sensorineural deafness with mild renal dysfunction,BSND
607459,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",POLG
182230,Septo-optic dysplasia,HESX1
611812,SERKAL syndrome,WNT4
400042,Sertoli cell-only syndrome,ZNF148
612780,SESAME syndrome,KCNJ10
102700,Severe combined immunodeficiency due to ADA deficiency,ADA
611291,"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation",NHEJ1
602450,"Severe combined immunodeficiency, Athabascan type",DCLRE1C
601457,"Severe combined immunodeficiency, B cell-negative",RAG1
601457,"Severe combined immunodeficiency, B cell-negative",RAG2
608971,"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive",CD3D
608971,"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive",CD3E
608971,"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive",PTPRC
608971,"Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type",IL7R
300400,"Severe combined immunodeficiency, X-linked",IL2RG
609620,Short QT syndrome-1,KCNH2
609621,Short QT syndrome-2,KCNQ1
609622,Short QT syndrome-3,KCNJ2
263510,"Short rib-polydactyly syndrome, type III",DYNC2H1
604271,Short stature,GHSR
300582,"Short stature, idiopathic familial",SHOX
300582,"Short stature, idiopathic familial",SHOXY
604271,"Short stature, idiopathic",GHR
182212,Shprintzen–Goldberg syndrome,FBN1
260400,Shwachman–Bodian–Diamond syndrome,SBDS
269920,"Sialic acid storage disorder, infantile",SLC17A5
256550,"Sialidosis, type I",NEU1
256550,"Sialidosis, type II",NEU1
269921,Sialuria,GNE
608567,Sick sinus syndrome 1,SCN5A
163800,Sick sinus syndrome 2,HCN4
603903,Sickle cell anemia,HBB
270685,Silver spastic paraplegia syndrome,BSCL2
180860,Silver–Russell syndrome,H19
312870,"Simpson-Golabi-Behmel syndrome, type 1",GPC3
300209,"Simpson-Golabi-Behmel syndrome, type 2",OFD1
210250,Sitosterolemia,ABCG5
210250,Sitosterolemia,ABCG8
270200,Sjögren–Larsson syndrome,ALDH3A2
612447,"Skeletal defects, genital hypoplasia, and mental retardation",ZBTB16
607655,Skin fragility-woolly hair syndrome,DSP
611742,"Skin/hair/eye pigmentation 9, dark/light hair",ASIP
608236,"Slowed nerve conduction velocity, AD",ARHGEF10
147891,Small patella syndrome,TBX4
184250,"SMED, Strudwick type",COL2A1
270400,Smith–Lemli–Opitz syndrome,DHCR7
182290,Smith–Magenis syndrome,RAI1
607326,Smith–McCort dysplasia,DYM
193230,Snowflake vitreoretinal degeneration,KCNJ13
147250,Solitary median maxillary central incisor,SHH
102200,"Somatostatin analog, resistance to",SSTR5
136900,Sorsby fundus dystrophy,TIMP3
117550,Sotos syndrome,NSD1
270550,"Spastic ataxia, Charlevoix-Saguenay type",SACS
607225,"Spastic paralysis, infantile onset ascending",ALS2
604187,Spastic paraplegia 10,KIF5A
270700,Spastic paraplegia 15,ZFYVE26
610250,Spastic paraplegia 31,REEP1
610244,Spastic paraplegia 33,ZFYVE27
612020,Spastic paraplegia 39,PNPLA6
613206,"Spastic paraplegia, 44",GJC2
604360,Spastic paraplegia-11,SPG11
605280,Spastic paraplegia-13,HSPD1
312920,Spastic paraplegia-2,PLP1
182600,Spastic paraplegia-3A,SPG3A
182601,Spastic paraplegia-4,SPAST
612539,Spastic paraplegia-42,SLC33A1
270800,Spastic paraplegia-5A,CYP7B1
600363,Spastic paraplegia-6,NIPA1
607259,Spastic paraplegia-7,PGN
603563,Spastic paraplegia-8,KIAA0196
245480,Specific granule deficiency,CEBPE
602081,Speech-language disorder-1,FOXP2
612690,"Spherocytosis, hereditary, type 5",EPB42
182900,"Spherocytosis, type 1",ANK1
270970,"Spherocytosis, type 3",SPTA1
612653,"Spherocytosis, type 4",SLC4A1
313200,Spinal and bulbar muscular atrophy of Kennedy,AR
611067,"Spinal muscular atrophy, distal, autosomal recessive, 4",PLEKHG5
300489,"Spinal muscular atrophy, distal, X-linked 3",ATP7A
182980,"Spinal muscular atrophy, late-onset, Finkel type",VAPB
301830,"Spinal muscular atrophy, X-linked 2, infantile",UBE1
253300,Spinal muscular atrophy-1,SMN1
253550,Spinal muscular atrophy-2,SMN1
253400,Spinal muscular atrophy-3,SMN1
271150,Spinal muscular atrophy-4,SMN1
604326,Spinocerebellar ataxia 12,PPP2R2B
605361,Spinocerebellar ataxia 14,PRKCG
606658,Spinocerebellar ataxia 15,ITPR1
607136,Spinocerebellar ataxia 17,TBP
610246,Spinocerebellar ataxia 28,AFG3L2
117210,Spinocerebellar ataxia 31,BEAN
608768,Spinocerebellar ataxia 8,ATXN8OS
608768,Spinocerebellar ataxia 8,ATXN8
607459,Spinocerebellar ataxia with epilepsy,POLG
606937,"Spinocerebellar ataxia, autosomal recessive 5",ZNF592
610743,"Spinocerebellar ataxia, autosomal recessive 8",SYNE1
612016,"Spinocerebellar ataxia, autosomal recessive 9",CABC1
607250,"Spinocerebellar ataxia, autosomal recessive with axonal neuropathy",TDP1
271245,"Spinocerebellar ataxia, infantile-onset",C10orf2
164400,Spinocerebellar ataxia-1,ATXN1
603516,Spinocerebellar ataxia-10,ATXN10
604432,Spinocerebellar ataxia-11,TTBK2
605259,Spinocerebellar ataxia-13,KCNC3
183090,Spinocerebellar ataxia-2,ATXN2
609307,Spinocerebellar ataxia-27,FGF14
600224,Spinocerebellar ataxia-5,SPTBN2
183086,Spinocerebellar ataxia-6,CACNA1A
164500,Spinocerebellar ataxia-7,ATXN7
225300,Split-hand/foot malformation 6,WNT10B
605289,"Split-hand/foot malformation, type 4",TP63
272460,Spondylocarpotarsal synostosis syndrome,FLNB
612350,"Spondylocheirodysplasia, Ehlers-Danlos syndrome-like",SLC39A13
608681,"Spondylocostal dysostosis, autosomal recessive 2",MESP2
609813,"Spondylocostal dysostosis, autosomal recessive 3",LFNG
277300,"Spondylocostal dysostosis, autosomal recessive, 1",DLL3
122600,"Spondylocostal dystostosis 4, autosomal dominant",GDF6
608728,Spondyloepimetaphyseal dysplasia,MATN3
612813,"Spondyloepimetaphyseal dysplasia, aggrecan type",ACAN
602111,"Spondyloepimetaphyseal dysplasia, Missouri type",MMP13
208230,Spondyloepiphyseal dysplasia tarda with progressive arthropathy,WISP3
313400,Spondyloepiphyseal dysplasia tarda,TRAPPC2
143095,Spondyloepiphyseal dysplasia with congenital joint dislocations,CHST3
608361,"Spondyloepiphyseal dysplasia, Kimberley type",ACAN
613330,Spondylo-megaepiphyseal-metaphyseal dysplasia,NKX3-2
271665,"Spondylometaepiphyseal dysplasia, short limb-hand type",DDR2
184252,"Spondylometaphyseal dysplasia, Kozlowski type",TRPV4
271700,Spondyloperipheral dysplasia,COL2A1
275355,"Squamous cell carcinoma, head and neck",ING1
275355,"Squamous cell carcinoma, head and neck",TNFRSF10B
184460,Stapes ankylosis with broad thumb and toes,NOG
300707,STAR syndrome,FAM58A
600110,Stargardt disease 3,ELOVL4
603786,Stargardt disease 4,PROM1
248200,Stargardt disease-1,ABCA4
149400,"Startle disease/hyperekplexia, autosomal dominant",GLRA1
184500,Steatocystoma multiplex,KRT17
108300,"Stickler syndrome, type I",COL2A1
604841,"Stickler syndrome, type II",COL11A1
184840,"Stickler syndrome, type III",COL11A2
184900,Stiff skin syndrome,FBN1
300434,Stocco dos Santos X-linked mental retardation syndrome,SHROOM4
137215,Stomach cancer,KRAS
185000,Stomatocytosis I,EPB72
609161,"Striatal degeneration, autosomal dominant",PDE8B
271930,"Striatonigral degeneration, infantile",NUP62
601559,Stuve–Wiedemann syndrome/Schwartz–Jampel type 2 syndrome,LIFR
300067,"Subcortical laminal heteropia, X-linked",DCX
271980,Succinic semialdehyde dehydrogenase deficiency,ALDH5A1
245050,Succinyl-CoA:3-oxoacid CoA transferase deficiency,OXCT1
222900,"Sucrase-isomaltase deficiency, congenital",SI
608800,Sudden infant death with dysgenesis of the testes syndrome,TSPYL1
272300,Sulfite oxidase deficiency,SUOX
260540,"Supranuclear palsy, progressive atypical",MAPT
601104,"Supranuclear palsy, progressive",MAPT
185500,Supravalvar aortic stenosis,ELN
265120,"Surfactant metabolism dysfunction, pulmonary, 1",SFTPB
610913,"Surfactant metabolism dysfunction, pulmonary, 2",SFTPC
610921,"Surfactant metabolism dysfunction, pulmonary, 3",ABCA3
108985,Sveinsson choreoretinal atrophy,TEAD1
185800,"Symphalangism, proximal",GDF5
185800,"Symphalangism, proximal",NOG
186100,"Syndactyly, type III",GJA1
186200,"Syndactyly, type IV",LMBR1
186300,"Syndactyly, type V",HOXD13
186500,"Synostoses syndrome, multiple, 1",NOG
186000,Synpolydactyly with foot anomalies,HOXD13
608180,"Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses",FBLN1
186000,"Synpolydactyly, type II",HOXD13
205400,Tangier disease,ABCA1
311900,TARP syndrome,RBM10
186570,Tarsal-carpal coalition syndrome,NOG
272800,Tay–Sachs disease,HEXA
601705,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy",FOXN1
610441,Testicular microlithiasis,SLC34A2
273300,"Testicular tumor, sporadic",STK11
273395,"Tetra-amelia, autosomal recessive",WNT3
187500,Tetralogy of Fallot,GDF1
187500,Tetralogy of Fallot,JAG1
187500,Tetralogy of Fallot,ZFPM2
187500,Tetrology of Fallot,NKX2E
604131,"Thalassemia, alpha-",HBA2
604131,"Thalassemia, Hispanic gamma-delta-beta",LCRB
603902,"Thalassemia-beta, dominant inclusion-body",HBB
604131,"Thalassemias, alpha-",HBA1
604131,"Thalassemias, beta-",HBB
187600,"Thanatophoric dysplasia, type I",FGFR3
249270,Thiamine-responsive megaloblastic anemia syndrome,SLC19A2
612921,Three M syndrome 2,OBSL1
187950,"Thrombocythemia, essential",JAK2
187950,"Thrombocythemia, essential",MPL
187950,"Thrombocythemia, essential",THPO
612004,Thrombocytopenia 4,CYCS
314050,"Thrombocytopenia with beta-thalassemia, X-linked",GATA1
604498,"Thrombocytopenia, congenital amegakaryocytic",MPL
313900,"Thrombocytopenia, X-linked",WAS
313900,"Thrombocytopenia, X-linked, intermittent",WAS
188000,Thrombocytopenia-2,FLJ14813
188030,"Thrombocytopenic purpura, autoimmune",FCGR2C
613116,Thrombophilia due to elevated HRG,HRG
612356,Thrombophilia due to heparin cofactor II deficiency,HCF2
613116,Thrombophilia due to HRG deficiency,HRG
176860,"Thrombophilia due to protein C deficiency, autosomal dominant",PROC
612304,"Thrombophilia due to protein C deficiency, autosomal recessive",PROC
612336,Thrombophilia due to protein S deficiency,PROS1
612348,"Thrombophilia, familial, due to decreased release of PLAT",PLAT
300807,"Thrombophilia, X-linked, due to factor IX defect",F9
236200,"Thrombosis, hyperhomocysteinemic",CBS
274150,"Thrombotic thrombocytopenic purpura, familial",ADAMTS13
607200,Thryoid dyshormonogenesis 6,DUOX2
188470,"Thyroid carcinoma, follicular",MINPP1
188470,"Thyroid carcinoma, follicular",NRAS
188550,"Thyroid carcinoma, papillary",GOLGA5
188550,"Thyroid carcinoma, papillary",NCOA4
188550,"Thyroid carcinoma, papillary",PCM1
188550,"Thyroid carcinoma, papillary",PRKAR1A
188550,"Thyroid carcinoma, papillary",TRIM24
188550,"Thyroid carcinoma, papillary",TRIM33
274400,Thyroid dyshormonogenesis 1,SLC5A5
274500,Thyroid dyshormonogenesis 2A,TPO
274700,Thyroid dyshormonogenesis 3,TG
274800,Thyroid dyshormonogenesis 4,IYD
274900,Thyroid dyshormonogenesis 5,DUOXA2
609698,"Thyroid hormone metabolism, abnormal",SECISBP2
188570,Thyroid hormone resistance,THRB
274300,"Thyroid hormone resistance, autosomal recessive",THRB
145650,"Thyroid hormone resistance, selective pituitary",THRB
188550,Thyroid papillary carcinoma,CCDC6
600334,"Tibial muscular dystrophy, tardive",TTN
103500,Tietz albinism-deafness syndrome,MITF
601005,Timothy syndrome,CACNA1C
300622,Tn syndrome,C1GALT1C1
607523,"Toenail dystrophy, isolated",COL7A1
106600,"Tooth agenesis, selective, 1, with or without orofacial cleft",MSX1
604625,"Tooth agenesis, selective, 3",PAX9
613097,"Tooth agenesis, selective, 6",LTBP3
313500,"Tooth agenesis, selective, X-linked 1",ED1
259600,Torg–Winchester syndrome,MMP2
137580,Tourette syndrome,SLITRK1
107480,Townes–Brocks branchiootorenal-like syndrome,SALL1
107480,Townes–Brocks syndrome,SALL1
606003,Transaldolase deficiency,TALDO1
275350,Transcobalamin II deficiency,TCN2
131705,Transient bullous of the newborn,COL7A1
608808,"Transposition of the great arteries, dextro-looped 1",MED13L
154500,Treacher Collins mandibulofacial dysostosis,TCOF1
612119,Trehalase deficiency,TREH
190320,Trichodentoosseous syndrome,DLX3
601606,"Trichoepithelioma, multiple familial, 1",CYLD1
190350,"Trichorhinophalangeal syndrome, type I",TRPS1
190351,"Trichorhinophalangeal syndrome, type III",TRPS1
601675,Trichothiodystrophy,ERCC2
601675,Trichothiodystrophy,ERCC3
601675,"Trichothiodystrophy, complementation group A",GTF2H5
234050,"Trichothiodystrophy, nonphotosensitive 1",C7orf11
613229,Trichotillomania,SLITRK1
609015,Trifunctional protein deficiency,HADHA
609015,Trifunctional protein deficiency,HADHB
190440,Trigonocephaly,FGFR1
602079,Trimethylaminuria,FMO3
174500,"Triphalangeal thumb, type I",LMBR1
174500,Triphalangeal thumb-polysyndactyly syndrome,LMBR1
158300,Trismus-pseudocamptodactyly syndrome,MYH8
608189,Tropical calcific pancreatitis,SPINK1
275900,Troyer syndrome,SPG20
191100,Tuberous sclerosis-1,TSC1
191100,Tuberous sclerosis-2,TSC2
610455,"Tumoral calcinosis, familial, normophosphatemic",SAMD9
211900,"Tumoral calcinosis, hyperphosphatemic",KL
211900,"Tumoral calcinosis, hyperphosphatemic, familial",FGF23
211900,"Tumoral calcinosis, hyperphosphatemic, familial",GALNT3
611521,Tyrosine kinase 2 deficiency,TYK2
277660,Tyrosinemia type II,TAT
276710,Tyrosinemia type III,HPD
254090,Ullrich congenital muscular dystrophy,COL6A1
254090,Ullrich congenital muscular dystrophy,COL6A2
254090,Ullrich congenital muscular dystrophy,COL6A3
276820,"Ulna and fibula, absence of, with sever limb deficiency",WNT7A
181450,Ulnar–mammary syndrome,TBX3
276880,Urocanase deficiency,UROC1
236730,Urofacial syndrome,HPSE2
276900,"Usher syndrome, type 1B",MYO7A
276904,"Usher syndrome, type 1C",USH1C
601067,"Usher syndrome, type 1D",CDH23
601067,"Usher syndrome, type 1D/F digenic",CDH23
601067,"Usher syndrome, type 1D/F digenic",PCDH15
602083,"Usher syndrome, type 1F",PCDH15
606943,"Usher syndrome, type 1G",SANS
276901,"Usher syndrome, type 2A",USH2A
276902,"Usher syndrome, type 3",CLRN1
605472,"Usher syndrome, type IIC",GPR98
611383,"Usher syndrome, type IID",WHRN
600630,UV-sensitive syndrome,ERCC6
192350,VACTERL association,HOXD13
239100,Van Buchem disease,SOST
607636,"van Buchem disease, type 2",LRP5
119300,van der Woude syndrome,IRF6
192315,"Vasculopathy, retinal, with cerebral leukodystrophy",TREX1
276950,VATER association with macrocephaly and ventriculomegaly,PTEN
192430,Velocardiofacial syndrome,TBX1
600195,"Venous malformations, multiple cutaneous and mucosal",TEK
603829,"Ventricular fibrillation, familial, 1",SCN5A
612956,"Ventricular fibrillation, paroxysmal familial, 2",DPP6
604772,"Ventricular tachycardia, catecholaminergic polymorphic, 1",RYR2
611938,"Ventricular tachycardia, catecholaminergic polymorphic, 2",CASQ2
192605,"Ventricular tachycardia, idiopathic",GNAI2
192950,"Vertical talus, congenital",HOXD10
610878,Vesicoureteral reflux 2,ROBO2
264700,"Vitamin D-dependent rickets, type I",CYP27B1
607473,"Vitamin K-dependent clotting factors, combined deficiency of, 2",VKORC1
277450,Vitamin K-dependent coagulation defect,GGCX
608161,"Vitelliform macular dystrophy, adult-onset",BEST1
193220,Vitreoretinochoroidopathy,BEST1
201475,VLCAD deficiency,ACADVL
604117,Vohwinkel syndrome with ichthyosis,LOR
124500,Vohwinkel syndrome,GJB2
193300,"von Hippel–Lindau disease, modification of",CCND1
193300,von Hippel–Lindau syndrome,VHL
193400,"von Willebrand disease, autosomal dominant",VWF
277480,"von Willebrand disease, autosomal recessive",VWF
177820,"von Willebrand disease, platelet-type",GP1BA
193500,Waardenburg syndrome type 1,PAX3
608890,Waardenburg syndrome type 2D,SNAI2
611584,"Waardenburg syndrome type 2E, with or without neurologic involvement",SOX10
148820,Waardenburg syndrome type 3,PAX3
277580,Waardenburg syndrome type 4A,EDNRB
613265,Waardenburg syndrome type 4B,EDN3
613266,Waardenburg syndrome type 4C,SOX10
193510,Waardenburg syndrome type IIA,MITF
103470,"Waardenburg syndrome/albinism, digenic",TYR
103470,"Waardenburg syndrome/ocular albinism, digenic",MITF
143200,Wagner syndrome 1,VCAN
600118,Warburg micro syndrome 1,RAB3GAP1
122700,Warfarin resistance,VKORC1
122700,Warfarin sensitivity,CYP2C9
613398,Warsaw breakage syndrome,DDX11
193520,Watson syndrome,NF1
277590,Weaver syndrome,NSD1
608328,"Weill–Marchesani syndrome, dominant",FBN1
277600,"Weill–Marchesani syndrome, recessive",ADAMTS10
613195,Weill–Marchesani-like syndrome,ADAMTS17
277610,Weissenbacher–Zweymüller syndrome,COL11A2
277700,Werner syndrome,RECQL2
193530,Weyers acrodental dysostosis,EVC
193670,WHIM syndrome,CXCR4
193900,White sponge nevus,KRT13
193900,White sponge nevus,KRT4
194071,Wilms' tumor 2,H19
194070,Wilms' tumor,BRCA2
194070,"Wilms' tumor, somatic",GPC3
194070,"Wilms' tumor, type 1",WT1
277900,Wilson's disease,ATP7B
301000,Wiskott–Aldrich syndrome,WAS
189500,Witkop syndrome,MSX1
226980,Wolcott–Rallison syndrome,EIF2AK3
194200,Wolff–Parkinson–White syndrome,PRKAG2
604928,Wolfram syndrome 2,CISD2
222300,Wolfram syndrome,WFS1
222300,"Wolfram-like syndrome, autosomal dominant",WFS1
278000,Wolman disease,LIPA
241080,Woodhouse–Sakati syndrome,C2orf37
194300,"Woolly hair, autosomal dominant",KRT74
278150,"Woolly hair, autosomal recessive 1",P2RY5
604379,"Woolly hair, autosomal recessive 2 with or without hypotrichosis",LIPH
278250,Wrinkly skin syndrome,ATP6V0A2
278300,"Xanthinuria, type I",XDH
278700,Xeroderma pigmentosum group A,XPA
610651,Xeroderma pigmentosum group B,ERCC3
278720,Xeroderma pigmentosum group C,XPC
278730,Xeroderma pigmentosum group D,ERCC2
278740,"Xeroderma pigmentosum group E, DDB-negative subtype",DDB2
278760,Xeroderma pigmentosum group F,ERCC4
278780,Xeroderma pigmentosum group G,ERCC5
278750,"Xeroderma pigmentosum, variant type",POLH
610965,XFE progeroid syndrome,ERCC4
300087,"X-inactivation, familial skewed",XIC
214100,Zellweger syndrome,PEX10
214100,Zellweger syndrome,PEX13
214100,Zellweger syndrome,PEX14
214100,Zellweger syndrome,PEX26
214100,Zellweger syndrome,PEX5
214100,Zellweger syndrome,PXF
214100,"Zellweger syndrome, complementation group G",PEX3
214100,Zellweger syndrome-1,PEX1
